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SYNOPSIS 
 A Comparative Study to assess the Effectiveness of Tegaderm Versus 
Dynaplaster upon Pain Perception and Occurrence of Infection During Removal 
among Children at Selected Hospitals, Chennai. 
The Objectives of the Study were, 
1. To assess the level of pain perception and occurrence of infection during 
removal of tegaderm versus dynaplaster among children.  
2. To compare the effectiveness of tegaderm versus dynaplaster upon pain 
perception and occurrence of infection among children. 
3. To determine the effectiveness of tegaderm versus dynaplaster among 
children. 
4. To determine the association between selected demographic variables and 
pain perception during removal of tegaderm versus dynaplaster among 
children. 
5. To determine the association between selected clinical variables and pain 
perception during removal of tegaderm versus dynaplaster among children. 
6. To determine the association between selected demographic variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children.  
7. To determine the association between selected clinical variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children. 
8. To determine the association between selected demographic variables and 
effectiveness of tegaderm versus dynaplaster among children.  
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9. To determine the association between selected clinical variables and 
effectiveness of tegaderm versus dynaplaster among children.  
10. To assess the level of satisfaction of nurses using tegaderm and 
dynaplaster. 
 
The conceptual framework for the study was based on king’s Goal 
Attainment Theory. A comparative study with Post-test only design was used. The 
study was conducted at Apollo Children Hospitals, Chennai. The study included 
60 children who were selected by purposive sampling 30 were in the intervention 
group I and 30 were in the intervention group II. The variables of the study were 
pain perception and prevalence of infection.  
 
An extensive review of literature and guidance by experts laid the 
foundation of development of demographic variable proforma, clinical variable 
proforma, effectiveness checklist, infection check list, wong baker’s pain scale 
and rating scale on level of satisfaction of nurses. The data collection tools were 
validated and reliability was established. The main study was conducted after the 
pilot study. 
 
The level of pain perception and prevalence of infection and effectiveness 
was assessed for tegaderm versus dynaplaster of children. The level of satisfaction 
of nurses was assessed among both the groups. The data obtained was analysed 
using descriptive and inferential statistics. 
 
 
 
 
v 
 
Major Findings of the Study were, 
  Most of the children were aged 1-3yrs (50%, 26%) Significant percentage of  
children were males (50%,60%),from nuclear family (53%,33%) with a family 
monthly income of 20000-30000 (40%,30%) and majority of the children 
were in  primary school (47%,67%) in both tegaderm & dynaplaster group of 
children  respectively. 
 Majority of the children with tegaderm and dynaplaster had no co morbid 
illness (97%,93%), significant percentage of children  had orthopaedic and 
surgical problems (63.3%,83.3%), most of the children received medications 
(57%,27%) through peripheral line (80%,93%) placed in  Bracheo cephalic 
vein (80%,93%). Most of the children were intravenous line dependent for 
more than three days (47%, 63%) and which was secured with tegaderm and 
dynaplaster (47%, 83.3%). Sixty percent of children with dynaplaster had 
complications. 
   It was noted that majority of children with tegaderm experienced no pain and 
had no infection during removal (63.3%,80%) and majority of children with 
dynaplaster experienced severe pain and had infection during removal 
(75%,43%). 
 It was noted that majority of the children using tegaderm had effective out 
come (90%) and (27%) had effective out come with dynaplaster. 
 Mean and  standard  deviation with regard to pain perception of  children  
while removing tegaderm was (M-1.06,SD-0.9) and while removing 
dynaplaster was (M-8.4,SD-2.46).The difference was significant at 
p<0.001level. The findings also revealed that the occurrence of infection in 
children while removing tegaderm was (M-0.2, SD-0.1) and while removing 
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dynaplaster was   (M-1, SD-0.4).The difference was significant at p<0.001 
level. Hence null hypothesis H01 was rejected. 
 The mean and standard deviation with regard to effectiveness of tegaderm was              
(M-26, SD-6.1) and dynaplaster group of children was (M-17, SD-2.6). The 
difference was significant at p<0.001 level. Hence the null hypothesis H02 was 
rejected. 
 There was significant association between selected demographic variables and 
pain perception with regard to monthly income ( 
χ2  =
12.1df = 1) among 
children with tegaderm and in children with dynaplaster age of child 
(
χ2
=5.25df =1),type of family(
χ2
=3.9,df =1) at p<0.001 p<0.05. Hence the null 
hypothesis H0 3was rejected. 
 There was significant association between selected clinical variables and pain 
perception in children on tegaderm with regard to diagnosis ( 
χ2  =
4.3df = 1)and 
in children with dynaplaster with regard to  dynaplaster insitu (
χ2
=4.78df =1) , 
site of intravenous line insertion, (
χ2
=4.5df =1) at p<0.05.Hence the null 
hypothesis H04 was rejected. 
 There was significant association between selected demographic variables and 
presence of infection among children with tegaderm in regard to area of 
residence, (χ2 =4.39df =1) and in children with dynaplaster with regard to type 
of family (
χ2
=4.7df =1) at p<0.05 dynaplaster. Hence the null hypothesis H05 
was rejected. 
 There was significant association between selected clinical variables and 
presence of infection among children with tegaderm and dynaplaster with 
regard to number of days of intravenous line insitu, (χ2 =4.39df = 1) at p<0.05. 
Hence the null hypothesis H06 was rejected. 
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 There was significant association between selected demographic variables and 
effectiveness of tegaderm with regard to age, (χ2 =5.0df = 1) and dynaplaster 
with regard to type of family (
χ2
=4.78,df =1) at p<0.05. Hence the null 
Hypothesis H07 was rejected. 
 There was significant association between selected clinical variables and 
effectiveness of tegaderm  with regard to diagnosis, ( 
χ2  =
4.2,df = 1)  and 
dynaplaster with regard to indications for intravenous line ( 
χ2  =
5.37,df = 1) at 
p<0.05.Hence the null hypothesis H08 was rejected. 
 The findings revealed that most of the tegaderm group of nurses were highly 
satisfied with tegaderm (90%), whereas (73%) of nursed using dynaplaster 
were moderately satisfied (73%). 
 
Recommendations 
 A study can be conducted on cost effectiveness of tegaderm versus 
dynaplaster. 
 A similar study can be done on umbilical vein securing in preterm babies. 
 A similar study can be done on a larger population to generalize results. 
 A study can be conducted to assess the occurrence of infection tegaderm pads 
used for surgical dressing among post operative children. 
 Similar study can be done on Endo tracheal tube intubation securing in 
preterm, term, neonates and children. 
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CHAPTER I 
INTRODUCTION 
Back ground of the study 
“A baby is God's opinion that the world should go on.”                                                         
             - Carl Sandburg 
 Children are the greatest gift God will give to you and their souls the 
heaviest responsibility He will place in your hands. Take time with them; teach 
them to have faith in God. Be a person in whom they can have faith. When you 
are old, nothing else you've done would have mattered as much. The Wealth of a 
nation is not so much in its economical and natural resources but it lies more 
decidedly in the kind and quality of the wealth of its children and youth. It is they 
who will be the creators and shapers of a nation’s tomorrow. The Children of 
today will be adults of tomorrow. Their quality and personality will determine the 
kind of destiny that beckons the nation. 
 
Pain is an unpleasant sensory and emotional experience usually produced 
by something that injures, or threatens to injure, the body. Pain begins with a 
stimulus, but is influenced by physiological and psychological factors before it 
becomes part of our consciousness. Pain is a global health problem which exists 
from birth to the last stage of the life. It’s a very unpleasant sensation that cannot 
be shared with others. Children are becoming increasingly subjected to a longer 
battery of invasive investigation which is painful .Assessing and treating pain in 
children can be difficult. Newborns and children are often unable or unwilling to 
communicate the presence, location and intensity of pain .Parents may be 
reluctant to acknowledge their child’s pain.  
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The American Academy of Paediatrics and the American pain society 
addressed the need for pain management in children in their joint statement 
presented in 2001.They noted that, despite comprehensive research anecdotal 
experience and ample knowledge from the past 10 to 15 years, the assessment and 
treatment of pain in children frequently remains inadequate Pain in children, and 
whether children feel pain, has been the subject of debate within the medical 
profession for centuries. Prior to the late nineteenth century, it was only in the last 
quarter of the 20
th
 century, that scientific techniques were finally established 
children definitely do experience pain, probably more than adults and has 
developed reliable means of assessing and treating it. 
 
The International Association for the Study of Pain IASP, 1979, defined 
pain as an unpleasant sensory and emotional experience associated with potential 
damage, or described in terms of such damage. It is the most common reason for 
seeking health care. The health personnel must have the knowledge and skills to 
assess pain, to implement pain relief strategies, and to evaluate the effectiveness 
of these strategies, regardless of the setting. 
 
Illness and hospitalization expose children to unfamiliar and unpleasant 
feelings. Since children have little experience and comprehension of pain, it can 
cause intimidation and anxiety for them. Millions of children undergo procedures, 
which cause considerable distress. Children requiring needle stick such as 
injections, IV catheters and blood sampling, view these procedures as frightening 
and as a significant source of pain. 
 
Although pain is something that we invariably want to escape or stop, it 
serves in several very important functions. Pain protects us by triggering a 
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reflexive withdrawal from something damaging before we can suffer further 
injury, such as when we drop a hot pan before we sustain extensive burns. It is 
also a warning system that lets us know when an injury is about to occur: the 
burning ache in our muscles during extreme exertion warns us to stop using them. 
Pain forces us to immobilize or protect an injured part, such as a broken ankle, 
thus giving it a chance to heal. Pain also lets us know when we need to seek 
medical help, and teaches us what behaviours to avoid in the future. 
 
Neonates and young infants have immature central nervous system, 
lacking myelination of pain fibres and therefore clinicians believed that these 
children are incapable of perceiving pain. Research has challenged this 
assumption and demonstrated that neonates and infants do indeed feel pain. They 
noted that the research supported the noceptive process between infants and adults 
differed, in that the infants primary transmission of pain impulses alone are non 
mylinated C fibres ,there is less precise pain signal transmission in the spinal cord 
and there is lack of descending inhibitory transmission. For this, infants may 
actually have a lower pain threshold and perceive pain more intensely than adults 
or older children. 
  
Da Silva (2010) & Delph (2011) say that nurses are responsible for 
maintaining peripheral vascular access without complications to the circulatory 
system or local tissue. Although it is a routine procedure, peripheral venipuncture 
is a complex, highly skilled process that can pose a risk for patients and health 
care professionals if not performed properly Moreover, IV insertions can be 
expensive and unpleasant, often causing additional institutional costs and staff 
time. Recent recommendations from the Centres for Disease Control and 
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Prevention 2010 indicates that peripheral Intravenous can remain in place for 96 
hours or more, as long as they are functioning properly and the patient is not 
showing signs of infection. In addition, the Joint Commission’s 2010 National 
Patient Safety Goals highlight the need to reduce risk of health care associated 
infections(The Joint Commission, 2010). Strategies such as better IV securement 
for increased patient comfort and safety are needed to prolong IV function while 
preventing complications of infections, phlebitis, extravasations, infiltration, 
occlusion, or accidental catheter withdrawal. 
 
In the United States, 15 million central vascular catheter (CVC) days (i.e., 
the total number of days of exposure to CVCs among all patients in the selected 
population during the selected time period) occur in intensive care units (ICUs) 
each year. Studies have variously addressed catheter-related bloodstream 
infections (CRBSI). These infections independently increase hospital costs and 
length of stay [2-5], but have not generally been shown to independently increase 
mortality. While 80,000 CRBSIs occur in ICUs each year, a total of 250,000 cases 
of Blood stream infections have been estimated to occur annually, if entire 
hospitals are assessed. By several analyses, the cost of these infections is 
substantial, both in terms of morbidity and financial resources expended. 
 
Tegaderm bandages are clear, waterproof dressings that can be placed over 
minor skin injuries, minor burns, IV sites and some surgical wounds. The 
manufacturer, 3M, recommends that Tegaderm dressings be changed a minimum 
of every seven days. Removing the dressing, cleaning the site and applying new 
dressing can help prevent wound infection. The best method for removing 
Tegaderm depends on the patient's age and skin sensitivity. 
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Need for the study 
 
There is an increasing focus on the recognition, assessment and 
management of pain in children. Children under go many painful procedures in 
different clinical environment. The paediatric nurse should be familiar with 
general concepts about the perception of pain in children. Many pain assessment 
tools have been developed and restructured to provide the clinical nurse specialist 
with valid and reliable scale to assess pain in children and assess the effect of 
intervention 
 
Securement and visualization of peripheral intravenous catheter sites PIV 
is a common problem for pediatric nurses. Infiltration of IV fluid can lead to 
serious complications. Quality data, staff nurse, and nursing administrations 
concern about lack of visualization of PIV sites led to the project to identify best 
evidence for securing PIVs so that they could be assessed easily. 
 
 Orlando (2008) conducted a study which implies that the while removing 
IV line on children with tegaderm experienced less pain and skin irritation when 
compared with other adhesives. An Integrative Review of Intravenous Securement 
Devices performing peripheral venipunctures and maintaining peripheral 
intravenous IV therapy sites are daily responsibilities for medical-surgical nurses. 
Many nurses regularly perform peripheral cannulation as part of their role Kelly, 
(2009) says IV access is used routinely for administration of drugs, fluids, 
nutrition, blood, and blood products Ahlqvist (2006) states that while 
venipuncture is the most common invasive procedure performed on hospitalized 
patients, very little research has been done on the best practices for stabilization of 
the IV site.  
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Nurses are responsible for maintaining peripheral vascular access without 
complications to the circulatory system or local tissue. Although it is a routine 
procedure, peripheral venepuncture is a complex, highly skilled process that can 
pose risk for patients and health care professionals if not performed properly 
Dasilva & Dias( 2010). Moreover, IV insertions can be expensive and unpleasant, 
often causing additional institutional costs and staff time .Recent 
recommendations from the Centre for Disease Control and Prevention (2010) 
indicates that peripheral IVs can remain in place for 96 hours or more, as long as 
they are functioning properly and the patient is not showing signs of infection. 
  
The Joint Commission’s 2010 National Patient Safety Goal high light the 
need to reduce risk of health care-associated infections. Strategies such as better 
IV securement for increased patient comfort and safety are needed to prolong IV 
function while preventing complications of infections, phlebitis, extra vasation, 
infiltration, occlusion, or accidental catheter with drawal.In this of infections, 
phlebitis, extra-vasation, infiltration, occlusion, or accidental catheter with 
drawal.In this integrative review, the current research on the effectiveness of IV 
securement devices will be reviewed and practical implications for evidence-
based practices in IV care for medical-surgical nurses will be provided.  
 
In addition, current unresolved questions will be high-lighted. Catheter 
stabilization increasingly is recognized as an important intervention in IV therapy 
and maintenance. With stabilization, less movement of the catheter occurs at the 
insertion site, and the catheter is less likely to be dislodged Gorski (2007). Despite 
the routine use of peripheral lines for IV access, very few studies have considered 
complications related to peripheral IV therapy Schears (2007). For this review, 
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catheter securement device was defined as a mechanical device that is used to 
preserve the integrity of the access device and to prevent catheter migration and 
loss of access Infusion Nurses Society INS 2006. The term stabilization often is 
used interchangeably with securement when referring to a structure, support, or 
foundation that makes something less likely to fall, give way, or become displaced 
INS (2011). 
 
Method of dressing the IV ensures security and depends upon the child's 
age, condition of the skin, site of the IV, child's activity and mobility. Either 
traditional tapes and Tubular-Fast or the tegaderm/mefix dressing is acceptable. In 
the United States it is estimated that there are 1.7 million health care–Associated 
infections HAIs resulting in approximately 99,000 deaths of these Deaths, 
approximately 31,000 are caused by bloodstream infections.  
 
Wenzel and Edmond calculated that nosocomial bloodstream infections 
represented the eighth leading cause of death in the United States. Overall, there 
are an estimated 249,000 bloodstream infections in United States hospitals each 
year. These bloodstream infections have been estimated to increase the duration of 
hospitalization by 7 to 21 days. Following systematic review of literature, Stone 
and colleagues4 estimated the attributable cost of a bloodstream infection as being 
between $36,441 and $37,078 (2002 dollars). More recently, Anderson and 
colleagues5 calculated the cost of nosocomial bloodstream infections as $23,242 _ 
$ 5184 (2005 dollars). 
 
Incidence rate statistics in the USA: Estimated 2.013 infections due to 
intravenous lines or catheters occurred per 1,000 hospital discharges excluding 
Immuno compromised or cancer patients and neonates in the US 2000 National 
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Healthcare Quality Report(AHRQ) DHHS, 2003 Estimated 1.89 infections due to 
intravenous lines or catheters occurred per 1,000 hospital discharges (excluding 
Immuno compromised or cancer patients and neonates  of people aged 0 to 17 in 
the US 2000 National Healthcare Quality Report, NHRQ, DHHS, 2003 Estimated 
1.89 infections due to intravenous lines or catheters occurred per 1,000 hospital 
discharges (excluding Immuno compromised or cancer patients and neonates of 
people aged 18 to 44 in the US 2000 National Healthcare Quality Report, AHRQ, 
DHHS, 2003. 
 
 Pediatric nurses at a 246-bed community-owned district hospital observed 
they were frequently attempting to rescue or restart peripheral intravenous catheter 
sites (PIVs) due to varied pediatric IV securement practices throughout the 
hospital. In the context of exemplary professional practice, an exploratory 
Evidence Based Practice (EBP) project was designed to increase knowledge about 
the best practices in maintaining and preserving pediatric PIVs. Little research 
was available describing optimal practice. Evidence regarding intermittent versus 
continuous infusion to maintain patency was equivocal. Securement and 
visualization of peripheral intravenous catheter sites PIV is a common problem for 
pediatric nurses. Infiltration of IV fluid can lead to serious complications. 
Quality/Risk data, staff nurse, and nursing administration concerns about lack of 
visualization of PIV sites led to an EBP project to identify best evidence for 
securing PIVs so they could be assessed easily. 
 
 Traditionally, PIVCs have been secured with medical tape, tape with 
transparent dressings, or tape and gauze. One study documented the use of IV 
catheter securement with tape as resulting in only an eight percent PIVC success 
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rate. In addition, excess use of tape may obscure the IV site, preventing early 
detection of complications, and increasing the potential for infection. 
Complications arise when Intravenous catheters and tubing connections are not 
properly secured. Some consequences of poor catheter securement include 
phlebitis, infiltration, dislodgement, leaking, infection, patient pain and 
dissatisfaction, patient safety concerns, nursing interruptions, and additional costs. 
In many cases, the PIVC needs to be removed and another restarted in a new 
location. 
 
 According to a large study comparing catheter stabilization devices to 
tape, unscheduled restarts when PIVCs are replaced after one or more have 
already failed,  account for between 40 percent and 70 percent of all PIVC 
insertions. Complication rates have been shown to be directly related to the 
method used for securing the PIVC setup to the patient.PIVC restarts increase the 
healthcare worker’s risk of exposure to blood borne pathogens, and every time it 
is necessary to re-stick a patient there is the potential for a healthcare worker to 
suffer a needle stick injury. With better stabilization and longer dwell times, 
healthcare institutions can reduce the risk to healthcare workers, patient 
discomfort, and accidental catheter dislodgement. 
 
 The 2011 Infusion Nursing Standards of Practice includes a standard on 
catheter stabilization that says, Vascular access device VAD stabilization shall be 
used to preserve the integrity of the access device, minimize catheter movement at 
the hub, and prevent loss of access. The 2011 CDC Guidelines for the Prevention 
of Intravascular Catheter-Related Infections states: Use a suture-less catheter 
securement device to reduce the risk of infection for intravascular catheters. While 
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this statement is most often associated with the risk of infection with central lines, 
recent evidence published in Infection Control and Hospital Epidemiology shows 
that the risk of infection with short PIVCs may be an under-recognized 
complication. 
 
 The Infusion Nursing Standards of Practice no longer list dressings alone 
as catheter stabilization devices. Although dressings protect the insertion site, 
there is little to no evidence that they enhance catheter stabilization by themselves 
or in combination with tape. The chosen catheter stabilization method should let 
you assess the catheter insertion site easily and should not alter the flow of blood 
or fluid through the catheter. A randomized, controlled trial showed that the built-
in stabilization platform of a closed IV catheter system used with an IV 
securement dressing provided effective stabilization. This combination provided 
significantly reduced dislodgement and could reduce the need for restarts and the 
associated costs. 
 
The size of the footprint of the stabilization appears to be a critical 
component. This would be either a stabilization device added to a traditional 
catheter hub or a platform built into the catheter design in combination with a 
dressing for catheter securement. One study documented a cost savings from 
fewer restarts and reduced nursing time when hospitals changed to a combined 
PIVC and stabilization device, even though upfront costs were higher. 
 
The researcher during her personal experiences in children’s ward had 
practically witnessed the reaction of children to painful procedures like heel prick, 
immunization, cannulation, vein puncture and removing IV line securing plaster. 
Increased education and research regarding child pains within the past two 
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decades have highlighted the issue, but appropriate pain utilization of pain 
management continues to be a problem. Removal of intravenous line securing 
plaster is a common procedure that all children need to undergo in order to protect 
the health from the pain and infection. Tegaderm patch is more useful while 
removing less pain will be there simultaneously preventing infections because of 
is made up chlorhexine. Whether pain is increasing or decreasing while removing 
tegaderm plaster and dynaplaster meanwhile assessing the pain using standard 
pain scale like neonatal infants pain scale and face limp activity cry and console 
scale. 
 
Statement of the Problem 
 
A Comparative Study to assess the Effectiveness of Tegaderm Versus 
Dynaplaster upon Pain Perception and occurrence of Infection during Removal 
among Children at Selected Hospitals, Chennai. 
 
Objectives of the Study 
 
1. To assess the level of pain perception and occurrence of infection during 
removal of tegaderm versus dynaplaster among children.  
2. To compare the effectiveness of tegaderm versus dynaplaster upon pain 
perception and occurrence of infection among children. 
3. To determine the effectiveness of tegaderm versus dynaplaster among 
children. 
4. To determine the association between selected demographic variables and 
pain perception during removal of tegaderm versus dynaplaster among 
children. 
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5. To determine the association between selected clinical variables and pain 
perception during removal of tegaderm versus dynaplaster among children. 
6. To determine the association between selected demographic variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children.  
7. To determine the association between selected clinical variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children. 
8. To determine the association between selected demographic variables and 
effectiveness of tegaderm versus dynaplaster among children.  
9. To determine the association between selected clinical variables and 
effectiveness of tegaderm versus dynaplaster among children.  
10. To assess the level of satisfaction of nurses using tegaderm versus 
dynaplaster 
 
Operational Definitions 
 
Effectiveness 
 In this study   it refers to the pain perception and occurrence of infection 
when using IV securement in the tegaderm and dynaplaster. The effectiveness is 
measured & compared with the outcome of intervention group I and group II of 
children using wongbaker faces scale, to assess the pain and infection checklist to 
assess the occurrence of infection. 
Children 
In this study it refers to the children from 1 year to 12 years whose 
intravenous line is secured with tegaderm & dynaplaster. 
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Nurses 
In this study it refers to a person who is a registered nurse working in 
pediatric ward or paediatric intensive care unit, cardiac intensive care unit & is 
and is able to apply tegaderm & dynaplaster. 
 
Out come 
In this study it refers to changes in pain perception, decreased occurrence 
of infections and increased satisfaction among nurses on intravenous line 
securement using tegaderm & dynaplaster. It is measured using checklist. 
 
Pain  perception. 
In this study it refers to the pain experienced by children during removal of 
tegaderm & dynaplaster and is measured by Wong bakers faces scale. 
 
Tegaderm 
In this study it refers to a transparent securing agent with anti viral and anti 
bacterial substance, which is used to secure an intravenous line.  
 
Dynaplaster 
 In this study it refers to an adhesive tape used to secure intravenous line 
 
Infection   
 In this study it refers to those children with intravenous line developing 
fever, urticaria, pain, redness, tenderness around the site after applying the 
securing tape and while removing the tape.  
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Assumptions 
 
 Children  do experience pain while  removal of  securing tape  from  
intravenous site 
 Skin integrity can be impaired during removal of securing tape 
 Infections can occur from intravenous tapes 
 
Null Hypothesis 
 
 Ho1 There will be no significant difference between pain perception and 
occurrence of infection among children during removal of tegaderm versus 
dynaplaster 
Ho2There will be no significant difference in the effectiveness of tegaderm versus 
dynaplaster. 
Ho3 There will be no significant association between selected demographic 
variables and pain perception of children during removal of tegaderm versus 
dynaplaster. 
Ho4 There will be no significant association between selected clinical variables 
and pain perception of children during removal of tegaderm versus dynaplaster. 
Ho5 There will be no significant association between selected demographic 
variables and occurrence of infection among children during presence of tegaderm 
versus dynaplaster. 
Ho6 There will be no significant association between selected clinical variables 
and occurrence of infection among children during presence of tegaderm versus 
dynaplaster. 
Ho7 There will be no significant association between selected demographic 
variables and effectiveness tegaderm versus dynaplaster. 
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Ho8 There will be no significant association between selected clinical variables 
and effectiveness of tegaderm versus dynaplaster. 
 
Delimitation 
 
The study was delimited to 
 Children aged from one year to twelve years. 
 Children using tegaderm. 
 Children using dynaplaster. 
 Children who are admitted in selected hospitals. 
 
Conceptual Framework  
 
The conceptual frame work deals with the interrelated concepts or 
abstractions assembled together in a rational scheme by virtue of their relevance to 
a common theme (Polit and Beck, 2008). 
 
The conceptual framework of present study is based on “king’s goal 
attainment theory”. According to Imogene king; nursing is defined as the process 
of action, reaction, whereby nurses and clients share the information about their 
perception. Through perception and communication they identified the problem 
through which they set goals and take necessary action. 
It was developed from an existing theory of interest and proposing 
relationship among them the theory gives direction 
 
King’s goal attainment theory is based on the concepts of personal, 
interpersonal and social systems including perception, judgement, action, reaction, 
interaction, transaction and perception. 
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Perception 
A person imports energy from the environment and transforms, processes 
and stores it. The study assumes that there is an interpersonal relationship between 
the nurse investigator and participants. The nurse investigator perceives that there 
is a need for the development of an alternative nursing care-tegaderm in group I 
and dynaplaster in group II to reduce the pain and prevalence of infections is 
assessed using observation check list and Wong baker’s pain scale. 
 
Judgement 
Analyse the areas of action to be carried out. In this study the nurse 
investigator judges whether tegaderm and dynaplaster reduce the pain while on 
removing both adhesives and reduces the complications. Thus the researcher takes 
decision to apply the tegaderm for group I and dynaplaster for group II. 
 
Action 
Reaction means developing action and acting on perceived choices for 
goal attainment. Here the reaction means decrease in pain and increased 
antimicrobial activity of Adhesives. The tegaderm applied the securing the 
intravenous line in group I children were highly satisfied and the dynaplaster 
applied the securing the intravenous line in group II children were satisfied. The 
nurse investigator makes the arrangement for disseminating the information 
regarding tegaderm adhesive for children were benefitted. 
 
Interaction 
 Interaction refers to verbal and non verbal behaviour between an 
individual and the environment or among two or more individuals. It involves 
goal directed perception and communication. Action leads to interaction where the 
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nurse investigator executes her removal of tegaderm and dynaplaster upon the 
pain perception and associated with the prevalence of infections with children 
receiving intravenous line. 
 
Transaction 
 Imogene king says that the transaction is two individual mutually identify 
goals and the means to achieve them. They reach an agreement about how to 
attain these goals and then set about to realize them. In this transaction occurs 
among nurse, child, family and other health team workers. 
 
Feed back 
 Outcome may either be highly satisfied or highly satisfied. Highly satisfied 
shows the effectiveness of tegaderm and satisfied shows the dynaplaster. In this 
study appraise the level of satisfaction on nurses through rating scale, if tegaderm 
and dynaplaster is satisfactory it can be disseminated and implemented clinical 
settings. If unsatisfactory the activity is planned again or other best method is 
adopted.  
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NURSE RESEARCHER 
PERCEPTION: Perceives need for securing 
intravenous line and removing adhesives at the 
time of discharge. 
JUDGEMENT: Comparing the Tegaderm and 
dynaplaster. Tegaderm reduces the pain, reduces the 
occurrence of infection, improves the child’s 
outcome and nurses satisfaction. 
ACTION: Plans to remove the securement 
adhesives for children at the time of discharge. 
CHILDREN 
ACTION: group I (Tegaderm) group II (Dynaplaster) 
JUDGEMENT: Tegaderm &Dynaplaster help to 
reduce the pain and occurrence of infections at the 
time of removal. 
PERCEPTION: Reduced pain and occurrence of 
infection during removal of adhesives assessed by 
observational checklist and Wong Baker’s pain 
scale. 
REACTION  
Group I:  
Tegaderm removal 
Group II: 
Dynaplaster removal 
 
INTERACTION 
Group I: Tegaderm reduces pain 
and occurrence of infection. 
Group II: Dynaplaster reduces pain 
and occurrence of infection. 
 
 
Tegaderm versus 
Dynaplaster  
 Pain perception 
 Tegaderm 
cause no Pain, 
Infection and 
More 
effective 
&Highly 
satisfied 
Dynaplaster 
cause severe 
Pain and 
Infection 
ineffective & 
moderately 
satisfied 
 
TRANSACTION 
 Group I: Pain scale assessment 
and nurse’s satisfaction 
Group II: Pain scale assessment 
and nurse’s satisfaction. 
 
 Infection 
No infection 
Infection  
Effective 
Moderately effective 
Ineffective 
No pain 
Mild pain 
Moderate pain 
Severe pain 
FEED BACK 
Effectiveness 
Fig:1 Conceptual Frame Work  based on modified kings goal attainment theory 
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Projected Outcome 
 
The projected outcome will be reduction of pain, decrease in complication, 
ease of removal, prevalence of infection, protection of IV site and increased in the 
level of satisfaction of nurses while applying and removing the adhesive tapes in 
children. 
 
Summary 
 
This chapter has dealt with the background, need for the study, and 
statement of the problem, objectives, operational definitions, assumptions null 
hypothesis, delimitations and conceptual framework. 
 
Organization of the Report 
 
Further aspects of the study are presented in the following five chapters. 
CHAPTER  II : Review of the literature. 
CHAPTER  III : Research methodology includes research approach,  
      research design, and setting, population,  
      sampling techniques, tool description, content  
      validity and reliability of tools, pilot study, data                                                                                                                           
      collection procedure and plan for data analysis. 
CHAPTER  IV   :  Analysis and interpretation of data. 
CHAPTER  V     :  Discussion. 
CHAPTER  VI        :  Summary, conclusion, implications and    
        recommendations. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
A literature review is an organised written presentation of what has been 
published on a topic by scholars (Burns & groove, 2004). This chapter deals with 
a review of published and unpublished research studies and from related material 
for the present study. The review helped investigator to develop an insight into the 
problem area. This helped the investigator in building the foundations of the 
study. 
 
The task of reviewing literature involves the identification, selection, 
critical analysis, and reporting of existing information on the topics of interest. A 
review acquaints the researcher with what has been done in the field and it 
minimizes possibilities of unintentional duplications. It justifies the need for 
replication provides the basis of future investigations and help to relate the 
findings of one study to another. 
 
The review of literature for this study is presented under the following headings:- 
 Literature related to securement 
 Literature related to pain in children 
 Literature related to infections in children       
 Literature related to comparison of tegaderm and dynaplaster 
 
Literature related to Securement  
Hetzler (2011) in United States study was conducted to assess the 
Improving Securement and Visualization of Pediatric Peripheral Intravenous 
Catheters, after a review of the literature, pediatric nursing staff initiated data 
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collection to determine the current pediatric PIV practices with the plan to 
evaluate and refine these practices to promote catheter survival times and decrease 
patient complications. Data on 60 PIV sites were analyzed and found 50 percent 
were discontinued in fewer than 24 hours. Securement practices were inconsistent. 
The most frequent reason for loss of IV site was infiltration 15, followed by 
patient pulling out 4, clot 1 and insertion site inflammation 1. Sixteen of 60 sites 
25 percent infiltrated before 72 hours. Pediatric RNs established a new peripheral 
IV securement protocol. This was communicated throughout the hospital’s 
departments that work with pediatric patients via a poster and simulation model. 
The exploratory evidence-based practice project work was translated into an 
article for publication. Tape stabilizing knuckle flexion and securing hand to arm 
board. Additional tape stabilizing thumb Elastic gauze netting secures site and 
lines, while providing nurse ability to visualize site. Placing fingers over end of 
arm board allows for flexion of fingers. This is preferred for infants. Support for 
participation in the 2011 Annual Pediatric Nursing National Conference has been 
generously provided by Kootenai Health Foundation. Improving Securement and 
Visualization of Pediatric Peripheral Intravenous Catheters. 
 
 Literature related to Pain in Children 
Orlando (2008) conducted a study which implies that the while removing 
IV line on children with tegaderm experienced less pain and skin irritation when 
compared with other adhesives.  The researcher with personal experiences in 
children ward had practically witnessed the reaction of children to painful 
procedures like heel prick, immunization, cannula, vein puncture and removing IV 
line securing plaster. Increased education and research regarding  child pains 
within the past two decades may highlighting the issue, but appropriate pain 
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utilization of pain management continue to be a problem. Removal of intravenous 
line securing plaster is a common procedure that all children need to undergo in 
order to protect the health from the pain and infection. Tegaderm patch is more 
useful while removing less pain will be there simultaneously preventing infections 
because of is made up chlorhexine. Whether pain is increasing or decreasing while 
removing tegaderm plaster and dynaplaster meanwhile assessing the pain using 
standard pain scale like neonatal infants pain scale and face limp activity cry and 
console scale 
 
A descriptive study conducted by Vak (2007) on children to view the 
sources of pain and explore the views on pain relief strategies. An exploratory 
cross sectional descriptive design and writes technique was used to investigate on 
what aids the children to think at the time of experiencing pain. The sample was 
composed of 33% boys and 64% girls of 4- 16 years. The result has shown that 
mean +_S.D:9.25, +_3.04 and few were different from the mean presented in the 
children texts and drawing based on developmental stage and on difference based 
on developmental stage and on difference based on gender.  
 
Owens (2004) in an article on comprehensive review pain measured for 
children aged between 0 and 3 years discussed their applicability to the group of 
children. Search of electronic data based and other electronic sources were 
supplemented by hand review of relevant journals to identify published measures 
for use in children aged between 0 and 3 years. Twenty eight pain measures were 
identified in the literature nine for neonates, ten for infants and nine for aged 
between one and 3 years. 
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A descriptive study to investigate the prevalence of pain and 
characteristics of pain frequency, duration, intensity among children and 
compared across different age and gender conducted by Priyadharshini Johnson 
(2004).In this study about 735 children from school were surveyed, in which 
results showed that 715(97.3%) have answered the questionnaires related to pain 
completely. The study concluded that the prevalence of pain, is increased with age 
and more pain was complained by female children. 
 
Literature related to Infections in Children 
Lynn Hadaway (2012) a study was performed that the rate of infections 
associated with short peripheral intravenous catheters is thought to be very low, 
even rare. Approximately 330 million peripheral catheters are sold annually in the 
United States. Although the rate may be low, the actual number of infections 
could be relatively high, with most going undetected because of short dwell times 
and early patient discharges. A recent estimate reported as many as 10000 
Staphylococcus aureus bacteraemia from peripheral catheters annually in the 
United States. This integrative literature review identified soft tissue, bone, and 
bloodstream infections. Analysis of 45 studies revealed significant knowledge 
gaps and inadequate clinical practices associated with one of the most common 
devices used in all health care settings. 
 
A retrospective study was conducted in United States by Trinh (2011) 
which proved that rate based on the total number of adult inpatient days and the 
number of patients with a peripheral catheter during a point-prevalence study 
conducted in 2008. The calculated rate was 0.06 bacteraemia per 1000 catheter-
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days. This represents a rate dramatically lower than what was reported by Maki  
of 0.2 to 0.7 bacteraemia per 1000 catheter-days. 
 
 The CDC's Guidelines for the Prevention of Intravascular Catheter-
Related Infections, (2011) include revised wording that states there is no need to 
replace peripheral catheters more frequently than every 72 to 96 hours for the 
purpose of reducing infection and states that changing the catheter in adults based 
only on clinical indication is an unresolved issue. The CDC states the following: 
"Remove peripheral venous catheters if the patients develop [sic] signs of 
phlebitis (warmth, tenderness, erythema, or palpable venous cord), infection, or a 
malfunctioning catheter." 
 
One randomized, controlled trial was conducted in united states by 
bausone-gazdad lefaiverc (2010) which proved that of stabilization for 
peripherally inserted central venous catheters PICCs reported on infections and 
stabilization. Systemic infections were confirmed in 8 patients and suspected in 2 
patients when the PICC was secured with sutures. With the stabilization device, 
there was 1 confirmed systemic infection and 1 suspected infection. Cellulites 
occurred in 5 secured with suture versus 3 secured with a stabilization device. 
There were 85 patients in each group of this study. This study is included because 
the insertion sites are on the upper extremity, and the burden of organisms on the 
skin would be very similar to those for peripheral catheter insertion. The 
differences would be a sterile procedure for PICC insertion versus a "clean" 
procedure for peripheral catheter insertion. Peripheral catheters are not sutured, 
which would add to skin disruption. These are the only available data on 
infectious complications and stabilization for any type of VAD. 
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Zingg (2009) a study was performed that rates of thrombophlebitis range 
from 2% to 80%. These rates are taken from 21 studies dating back to 1973. Many 
factors related to the catheter, drugs, patient, and health care personnel contribute 
to thrombophlebitis. Data from the above literature review were used to report 
rates of BSI. Zingg also state that there is a widely held assumption that 
thrombophlebitis can become Blood stream infection. The connection between 
thrombophlebitis and BSI and the burden of BSI from short peripheral catheters 
has not been convincingly established through the available studies. The authors 
included 10 studies, dating back to 1975, to report that an estimated 5% to 25% of 
peripheral catheters were colonized with bacteria at the time of removal. Reasons 
given for the very low BSI rates with relatively high rates of colonization include 
the short dwell time and fewer manipulations of the peripheral catheter and lack of 
appropriate surveillance. The rate of local infection associated with peripheral 
catheters was reported to be 2.3% 9 out of 390 catheters in an Italian study18-a 
study that was also included in the work by Zingg and Pittet. No description of 
these infections was provided Palefski 2001did a study was performed  on 
assessed complications in 776 peripheral catheters-639 inserted by infusion nurses 
and 137 by generalist nurses. Thirty-six percent (36%) of catheters inserted by the 
generalists and 20% inserted by infusion nurses were removed for complications 
(P <= .001). Cellulites, infection, and sepsis were tracked by clinical signs and 
symptoms, but none were reported in either group. 
 
Nahiriya (2009) of Uganda stated that cultured hubs and tips on removal of 
391 peripheral catheters in hospitalized pediatric patients. Tips were colonized in 
20.7%, hubs were colonized in 11.25%, and 4.86% had the same organisms 
growing in both the hub and tip. S. aureus was the most prevalent organism, 
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followed by S. epidermidis. The study provided no information on skin antisepsis, 
catheter stabilization, dressing, or experience of personnel performing the 
insertions.  
 
Cunha (2008) a study was performed on Centrally-placed IV-line 
infections are a frequent cause of fever in the critical care unit. IV-line infection is 
not usually accompanied by local signs of infection, and usually presents as 
unexplained fever. The diagnosis should be considered only after other causes of 
fever have been ruled out. The likelihood of fever being due to IV.-line infection 
increases with duration of IV catheterization. Skin organisms i.e., Staphylococcus 
epidermidis / coagulase-negative staphylococci, and to a lesser extent, 
Staphylococcus aureus are the usual pathogens in IV line infection. Treatment of 
IV -line infection involves removal of the IV line. Empiric antibiotic therapy 
directed against gram-positive cocci/aerobic gram-negative bacilli is usually 
started after blood cultures have been obtained and removed catheter tip sent for 
semi quantitative culture. 
 
England (2004) and the Republic of Ireland participated in a point-
prevalence study on all health care-acquired infections HCAIs in 2004. The 
overall prevalence was 7.6% in 75 694 patients. Primary BSIs were reported in 
264 out of 28 987 (0.9%) patients with a current peripheral catheter; patients who 
had a peripheral catheter within the previous 7 days produced 48 out of 17 595 
(0.3%) BSIs. Patients with a CVC revealed the highest BSI rates of 5%, and those 
having a CVC within the previous 7 days showed a rate of 2.3%.Lee et al (2009) a 
study was performed that two studies assessed the skill of inserters in relation to 
peripheral catheter outcomes. Reported that peripheral catheters inserted by the 
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emergency department nurses had a greater rate of phlebitis than those inserted by 
IV therapists: 3.7% vs 2.1%, with an odds ratio of 1.6 (1.003-2.5, 95% CI, P = 
.048). The language in this study indicates that the authors equate phlebitis to 
infection because 160 of 162 phlebitis cases had microbiological evidence of 
infection. No site purulence or BSIs were reported. 
 
Norberg (2003) in an article assessed rates of false-positive blood cultures 
when samples taken during peripheral catheter insertion were compared with 
blood samples obtained from a separate venipuncture. They reported a 70% 
reduction in the false-positive rates when a separate, direct venipuncture site was 
used. This study did not report details of the skin antisepsis procedures and simply 
stated that they were "standardized." The authors speculated that the differences 
were related to the ease of drawing the sample when the peripheral catheter was 
inserted, leading to indiscriminate prescribing of blood cultures. 
 
Palefski (2001) Only two studies were found with some infection 
information on peripheral catheters from alternative health care settings. 
Compared outcome data from peripheral catheters inserted by infusion nurses in 
hospitals and home infusion agencies versus those inserted by generalist nurses. 
Complications were fewer in those inserted by infusion nurses; however, the data 
were not reported by type of health care setting. 
 
Literature related to Effectiveness of Tegaderm and Dynaplaster 
Travis (2011) in united states conducted study to describe Medical 
adhesive bandages are extensively used in both inpatient and outpatient medicine. 
However, few reports describing proven allergic contact dermatitis ACD from 
medical adhesive bandages exist in the literature. These reports do not adequately 
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correspond to the frequency that patients report having an "allergy" to medical 
adhesive bandages. To determine if there is a chemical present in medical 
adhesive bandages that causes ACD in people who identify themselves as having 
an "allergy" to medical adhesive bandages. Twenty-six patients were enrolled and 
underwent patch testing with our standard trays 104 chemicals and a customized 
adhesive tray 54 chemicals and 10 tapes and bandages in their whole form. We 
were able to identify an allergen in four patients that was related to their presumed 
adhesive allergy Mastisol, neomycin/bacitracin two different patients, and 
cortisone-10 cream, respectively. However, there were no positive allergic 
reactions to the tapes or bandages or any relevant allergic reactions to our 
customized adhesive tray. Eight (73%) of the 11 patients who had the bandage or 
tape left on for 7 days had an irritant reaction. 
 
A prospective post-authorization observational product study was conducted 
by Blackwell (2011) in United States to describe the meaning of the wound area 
reduction and healing rate, the occurrence of adverse events was documented. 
This study demonstrated a wound size reduction of at least 50 % for 72.9 % of the 
patients with therapy-refractory chronic wounds when treated with Tegaderm 
Matrix. The safety profile was evaluated; only 4.7 % of the patients experienced a 
treatment-related adverse event such as a burning sensation. The results of the 
study demonstrate that Tegaderm™ Matrix along with treatment of underlying 
causes is a well tolerated wound dressing promoting wound size reduction up to 
healing for the majority of patients with previously therapy-refractory chronic 
wounds. 
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Stacie (2011) in United States conducted a study to compare 3 different 
dressings with respect to effect on bleeding, discomfort voiced by patients, and 
ease of groin assessment in patients after percutaneous transluminal coronary 
angiography. A total of 100 patients were randomly assigned to 1 of 3 groups: 
pressure dressing, transparent film dressing, or adhesive bandage. Outcome 
variables were bleeding, patient discomfort, and nurse-reported ease of 
observation of the groin site. Results no bleeding occurred in patients with 
transparent film dressings or adhesive bandages. Patients rated these dressings 
significantly higher than they rated the pressure dressing. Because two-thirds of 
the sample had previously undergone percutaneous transluminal coronary 
angiography, they could compare their experience with the new dressing with 
previous experiences with pressure dressings. Nurses rated the ease of assessing 
the groin significantly higher for the transparent film and adhesive bandage 
dressings than for pressure dressings. As a result of this study, a practice change 
was made hospital-wide: rather than a standard opaque pressure dressing, a 
transparent film dressing is used for all patients after removal of a femoral sheath. 
 
Haskell  (2008) a study was performed on Allergic contact dermatitis from 
dodecyl maleamic acid in Curad adhesive plastic bandages Two patients, who 
developed eczematous eruptions beneath Curad-brand medical adhesive plastic 
bandages, were found to have allergic contact dermatitis to N-dodecyl maleamic 
acid. N-dodecyl maleamic acid is a monomer used in the production of the 
adhesive in Curad bandages. Our patients were also sensitive to several closely 
related chemical compounds. We discuss the chemical requisite for allergenicity 
of these compounds. These are the first documented cases of allergic contact 
dermatitis from dodecyl maleamic acid. 
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Boonbaichaiyapruck (2001) stated in their article that Post cardiac 
catheterization puncture site care is usually done with a tight pressure dressing by 
an elastic adhesive bandage Tensoplast due to the belief that it should prevent 
bleeding. The practice is uncomfortable to the patients. The authors compared a 
new way of dressing using light transparent tape Tegaderm to the conventional 
tight pressure one. 126 post coronary angiography patients were randomized to 
have their groins dressed either with Tensoplast or with Tegaderm. Patients 
ambulated 8 hours after the procedures. The groin was evaluated for pain, 
discomfort and bleeding complications. 49 per cent in the Tensoplast vs 26.9 per 
cent in the Tegaderm group experienced pain p value of 0.01. 55.5 per cent in the 
Tensoplast group vs 11.1 per cent in the Tegaderm group reported discomfort. 4.7 
per cent in the Tensoplast vs 1.6 per cent in the Tegaderm group developed 
bleeding or hematoma. Dressing of the puncture site after cardiac catheterization 
with Tegaderm was more comfortable than the conventional Tensoplast without 
any difference in bleeding complications. 
 
Madeo (1998) studied the purpose of this trial was to prepare for a large 
randomized trial comparing Arglaes film dressing, a recent innovation containing 
silver ions, against Tegaderm, a transparent polyurethane dressing. Thirty-one 
patients admitted to the intensive care unit and requiring the insertion of an 
arterial line or central venous catheter were recruited into the study. Skin swabs 
were taken from the insertion sites prior to catheterization and on removal of the 
intravascular device to measure skin colonization rate between the two dressings. 
The catheter tips were also cultured on removal to establish if there was a 
difference between the two groups. No statistical differences were found in 
bacterial growth between the two dressings. 
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Randomised controlled trial was conducted Tripepi-Bova (1998) in united 
states  to Compared with gauze dressings, can transparent polyurethane dressings 
TPDs reduce patient dislodgment of peripheral intravenous IV catheters, phlebitis, 
and insertion site infiltration. 108 patients were allocated to TPDs Smith and 121 
were allocated to gauze dressings 5 x 5 cm Johnson and Johnson Texas. Fewer 
patients who had TPDs dislodged the IV catheter compared with patients who had 
gauze dressings  p< 0.05. Rates of phlebitis and infiltration did not differ, although 
there was a trend toward a lower frequency of phlebitis and infiltration in patients 
assigned to TPDs. They found that transparent polyurethane dressings on 
peripheral IV sites resulted in fewer catheter dislodgments by patients than did 
gauze dressings. Non-significant trends for lower rates of phlebitis and IV site 
infiltration were found for patients who had transparent polyurethane dressings. 
 
 
Meylan (1987) performed a study on that while transparent polyurethane 
dressings are increasingly used for the care of intravenous catheters, concern has 
recently been expressed regarding their microbiological safety. We have therefore 
compared the rate of intravenous catheter bacterial colonization after randomly 
assigning intensive care patients to transparent polyurethane n = 21 or dry gauze n 
= 20 dressings. Polyvinyl chloride catheters were inserted and maintained by the 
nurses. No antiseptic or antibiotic ointment was used. The two groups of patients 
were similar regarding risk factors for catheter colonization. Colonization rate was 
48% 10/21 among patients with transparent dressings versus 10% 2/20 among 
patients with dry gauze dressings p = 0.008. Colonizing bacterial species were 
Staphylococcus epidermidis 11 strains and S. aureus 1 strain. No catheter-related 
bacteremia was observed. These data suggest that the colonization rate of 
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intravenous catheters is increased by the use of polyurethane dressings, possibly 
increasing the risk of septic phlebitis and bacteremia.  
 
Andersen (1986) study was conducted to comparative study of 'Op-site' 
and 'Nobecutan-gauze' dressings for central venous lines was performed. Seventy-
seven long ante brachial and 68 infraclavicular subclavian catheters were studied. 
A statistically significant reduction in the incidence of positive cultures from the 
catheter tip and from the skin puncture site was found with the 'Nobecutan-gauze' 
dressing.  They found that no difference in the incidence of catheter-related 
septicaemia was found. The theoretical advantage of being able to observe signs 
of inflammation when 'Op-site' was used did not reduce the incidence of local 
infection at the skin puncture site. In conclusion we found that a 'Nobecutan-
gauze' dressing was a satisfactory alternative to an 'Op-site' dressing. 
 
A randomized, prospective, controlled trial study was conducted by 
Littenberg   in united states to describe the three different dressings for peripheral 
intravenous catheters in 301 acutely ill medical inpatients. Catheters were dressed 
with dry clean gauze or one of two brands of transparent plastic. The gauze 
dressings remained in place significantly longer 47 hours median than either 
Uniflex 39 hours of Tegaderm 32 hours transparent plastic dressings p = 0.026. 
Catheters were removed for complications inflammation, mechanical failure, or 
infiltration in 35% of the gauze group, compared with 58% of the Uniflex group 
and 48% of the Tegaderm group p = 0.015. Not only were inflamed venipuncture 
sites seen less often with gauze, inflammation occurred later p = 0.002 and with 
lesser severity. Dry gauze dressings resulted in longer catheter life, lower 
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complication rates, and less expense than transparent plastic dressings for 
peripheral intravenous catheters. 
 
Conly stated in their article that Patients having central venous catheters 
for three or more days were prospectively randomized to receive a transparent n = 
58 or gauze n = 57 dressing to compare the incidence of insertion site 
colonization, local catheter-related infection, and catheter-related sepsis. 
Quantitative cultures of the catheter insertion site 25 cm2 revealed significantly 
greater colonization P less than or equal to .009after 48 hrs in the transparent 
versus the gauze dressing group. Local catheter-related infection occurred 
significantly more often P = .002 in the transparent 62% than in the gauze group 
24%. Seven episodes of catheter-related bacteremia occurred in the transparent 
group 16.6% and none in the gauze group P = .015. Stepwise logistic regression 
analysis revealed that cutaneous colonization at the insertion site of greater than or 
equal to 10(3) cfu/mL relative risk, 13.16 and difficulty of insertion relative risk, 
5.39 were significant factors for catheter-related infection. These data suggest that 
transparent dressings are associated with significantly increased rates of insertion 
site colonization, local catheter-related infection, and systemic catheter-related 
sepsis in patients with long-term central venous catheters. 
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Summary 
 
This chapter has dealt with review of literature related to the problem 
stated. The literatures presented here were extracted from Mediscape, Medline and 
Journal of Indian pediatrics. It includes fifteen primary sources and ten secondary 
sources. It has helped the researcher to understand the impact of problem under 
study. It has also enabled the investigator to design the study, develop the tool, 
and plan the data collection procedure and to analyze the data. 
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CHAPTER III 
RESEARCH METHODOLOGY 
 
The methodology of the research study is defined as the way the data are 
gathered in order to answer a question to analyse the research problem. It enables 
the researcher to project a blue print for the research undertaken. The research 
methodology involves a systematic procedure by which the researcher had a start 
from the initial identification of the problem to its final conclusion (polit and 
Beck, 2008). 
 
The present study is conducted to assess the effectiveness of tegaderm 
versus dynaplaster upon pain perception and prevalence of infection during 
removal among children. This chapter deals with a brief description of different 
steps undertaken by the researcher for the study. It involves research approach, 
research design, setting population, sample and sampling technique, sampling 
criteria selection and development of the instruments, validity and reliability of 
the instruments, pilot study, data collection procedure and plan for data analysis.  
 
Research Approach 
 
Research approach is the most significant part of the research. The 
appropriate choice of research approach depends upon the purpose of research 
study which is undertaken. According to Polit and Beck (2008) evaluation 
research is an extremely applied from of research and involves finding out how 
well a program and practice of policy are working. It goals are to assess or 
evaluate the success of program. In this study the researcher compared the 
effectiveness between tegaderm versus dynaplaster upon pain perception among 
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children. After review of literature the researcher found that comparative approach 
will be considered as the most appropriate approach for the study. In this study, 
the investigator assessed the pain while removing on dynaplaster and after 
implementing tegaderm found the effectiveness by using experimental research 
design. 
 
Research Design 
 
The overall plan for addressing a research question, including specification 
for enhancing study’s integrity is called as research design. A research design 
incorporates the most important methodological design that the researcher works 
in conducting a research (polit and Beck 2008). 
 
Evaluative research design was adopted for conducting this study. It fulfils 
the criteria such as manipulation, control and randomization. A Post test only 
design was adopted for conducting this study. 
X1     : 01 
X2     :  02 
X1     :  Removal of Tegaderm  
X2     :  Removal of Dynplaster  
01       : Pain perception and occurrence of infection in children with Tegaderm. 
02       :  Pain perception and occurrence of infection in children with Dynaplaster. 
 
Variables 
 
Independent variable 
The variable that is believed to cause or influence the dependent variable is 
the independent variable (Polit and Beck, 2008).In this study, the independent 
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variable is pain perception and occurrence of infection among children undergoing 
intravenous securement.      
 
Dependent variable 
The variable hypothesized to depend on or be caused by another variable is 
the dependent variable. In this study tegaderm and dynaplaster are considered as 
dependent variable. 
 
Attribute variable 
 The variables that describe study sample characteristics are termed as 
attribute variables (Polit and Beck, 2008).In this study attribute variables are 
demographic variables of the children and clinical variables of children 
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Fig:2 Schematic Representation of the Research Design 
Target Population (Children Whose Intravenous Line Is Secured With Tegaderm 
Versus Dynaplaster In The Pediatric Wards And Intensive Care Units) 
Accessible Population (Children Whose Intravenous Line Is Secured With Tegaderm 
Versus Dynaplaster  In The Pediatric Units And Intensive Care Units Of Apollo Children’s 
Hospital, Chennai 
Purposive 
sampling technique 
Demographic variables 
Clinical variables 
 
 Observe the Pain Perception by Wong 
Baker’s pain scale 
 Check the Effectiveness of Adhesives by 
check list 
 Observe for Occurrence of Infection by 
observational check list 
 
Satisfaction of nurses using Tegaderm and 
Dynaplaster assessed using rating scale for 
nurses 
Analysis and Interpretation 
 
Dynaplaster Tegaderm 
Removing Tegaderm 
 
Removing Dynaplaster 
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Research Setting 
 
Settings are the most specific places where data collection will occur (Polit 
& Beck, 2008).The present study was conducted at Apollo Children’s Hospitals. 
Apollo Children’s Hospital is an 80 bedded hospital under the administration of 
Apollo Hospitals situated in Chennai. It is a multispecialty tertiary centre for 
paediatrics with facilities like neonatal intensive care unit(NICU),pediatric 
intensive care unit(PICU),Cardio thoracic intensive care unit (CTICU),pediatric 
emergency services and subspecialties and is equipped with high frequency 
oscillation ventilator, 3D Echo Doppler, computed tomography and magnetic 
resonance imaging. The researcher collected data from sunshine ward, deluxe 
ward ,CTICU. 
 
Population 
 
 Population is the entire aggregation of cases which meets designed set of 
criteria (Polit and Beck, 2008). 
 
Target population is the group of population that the researcher aims to study 
and to whom the study findings will be generalized. In this study target population 
comprises of all children with intravenous line secured with the tegaderm versus 
dynaplaster.  
 
Accessible population is the population that the researcher finds in the study area. 
The accessible population in this study were children with intravenous line 
secured with tegaderm and dynaplaster in pediatric cardiac intensive care unit   
pediatric general wards and deluxe ward at Apollo Children’s Hospitals ,Chennai. 
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Sample 
 
  A sample consists the subset of the units which comprises the population 
(polit and Beck, 2004). A sample of  30 children whose intravenous line is secured 
with tegaderm and 30 children whose intravenous line secured with dynaplaster. 
 
Sampling Technique 
 
 Sampling is the process of selecting portion of the population to represent 
the entire population (Polit & Beck, 2008). The subjects of the study were selected 
by purposive sampling. 30 children were assigned to tegaderm group and 30 
children were assigned to dynaplaster group. 
 
Sampling Criteria 
 
Inclusion criteria 
 Children aged from one year to twelve years. 
 Children with tegaderm and dynaplaster used for securing the intravenous 
line. 
 Caregivers’ who are willing to participate in the study.  
 Children who were admitted in Apollo Children’s Hospital  
 
Exclusion criteria 
 Children who have intravenous line secured with other adhesives. 
 Children less than one year. 
 Children who are critically ill. 
 Nurses  who are not willing to participate in the study 
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Selection and Development of the Study Instruments 
 
As the study aimed to evaluate the effectiveness tegaderm and dynaplaster 
for children underwent intravenous line securement. The data collection 
instruments were developed through an extensive review of literature and in 
consultation with opinion of experts and opinion of faculty members. The 
instruments used in this study are demographic variable proforma, clinical 
variable proforma, effectiveness check list, infection checklist ,Wong bakers pain 
scale and nurse’s satisfaction rating scale. 
 
Demographic variable proforma for children  
 
Demographic variables for children includes age, gender, type of family, 
and area of residence, family monthly income, and educational status of the 
children. 
 
Clinical variable proforma for children 
 
This proforma includes clinical variables like age at diagnosis, co-morbid 
illness, diagnosis, indications of intravenous line, type of intravenous line, site of 
intravenous line, type of adhesive material, number of days of 
tegaderm/dynaplaster, number of days of intravenous line, any intravenous 
complication. 
 
 Wong Bakers Faces Pain rating scale  
Wong Baker Faces pain rating scale is a subjective pain rating scale 
developed by  Wong and Baker (1988).It consists of six cartoon faces ranging  
from smiling face for “no pain” to tearful for “worst pain” .It can be used for 
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children as young as 3 years. The FACES provide three scales in one: facial 
expression, numbers, and words. The score ranging from 0 – no pain,2-hurts little 
bit,4 – hurts little more,6 – hurts even more,8 – hurts whole lot,10 – hurts worst. 
The score interpretation is mentioned below 
0    No pain 
2                   Mild pain 
4   & 6         Moderate pain 
8   & 10         Severe pain 
 
Observational check list to the assess presence of infection  
 
  Infection checklist was developed by the investigator which includes 
observations like presence of fever, urticaria, pain at the site of cannula insertion, 
redness etc. It included 8 statements and it is of yes or no type. The scoring was 1 
for yes and 0 for no infection 
 
Score                Percentage                Level of infection 
<4                     <50                               No infection         
5 – 8                 50 – 100                        Infection 
 
Observational check list on effectiveness of dynaplaster versus tegaderm 
 
 Effectiveness of intervention check list was developed by the investigator. 
It included 10 statements. The scoring was 3 for effective, 2 for moderately 
effective and ‘1’ for ineffective. 
Score                Percentage                             Interpretation 
< 10                   <33                               Ineffective  
11 – 20                      34 – 66                         Moderately effective 
21 – 30                   67 – 100                              Effective 
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Rating scale on level of satisfaction of nurse 
 
A four point rating scale was developed by the investigator, it is a self 
administered. It assesses the level of nurse’s satisfaction regarding tegaderm and 
dynaplaster. It consists of 10 statements. The total score is 100 
 
Score                Percentage             Interpretation 
<10                      <25                           Dissatisfied 
11-20                  26 -50                      Satisfied 
21-30                  51 -75                        Moderately satisfied 
31-40                    76 -100                      Highly satisfied 
 
Psychometric Properties 
 
Validity of study instruments 
Content validity refers to the adequacy of the sampling of the domain 
being studied. The content validity of the tool was obtained by getting opinion 
from six experts in the field of pediatrics. Two of the experts were doctors and 
four were nursing experts including nurse educator in clinical field. The validation 
has suggested some specific modifications in the tools and rating scale. The 
modifications and suggestions of experts were incorporated in the final 
preparation of the tool. 
 
Reliability of the instruments 
 Reliability is the degree of consistency with which an instrument 
measures the attribute it intended to measure (polit &Beck, 2008), the reliability 
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of the tools was determined by using split half method and interrater 
technique.karl Pearson’s r was computed for finding out the reliability. 
  
Occurrence of Infection checklist           Inter rate technique (r=0.88) 
Effectivenesscheck list for  
Tegaderm versus dynaplaster    Split half method(r=0.94) 
Rating scale for level of satisfaction     Split half method(r=0.84)  
 
Pilot Study 
 
According to Polit and Beck. (2009), a polit study is a miniature or some 
part of the actual study, in which the instrument are administered to the subjects 
drawn from the population. it is a small scale version or trail run, done in 
preparation for the major study. The purpose is to find out the feasibility to 
conduct main study. 
 
 Pilot study was conducted with six children who had intravenous line 
securement with tegaderm and dynaplaster in Apollo children’s hospital, Chennai. 
The observation checklist for infection and effectiveness, rating scale, and pain 
scale administered was found to be feasible. 
 
Protection of Human Rights 
 
The researcher presented the proposal to the ethical committee of Apollo 
hospitals and got clearance to conduct the study. The researcher obtained 
permission to conduct the study from principal and HOD, Pediatric nursing 
department of Apollo college of nursing. Informed consent was obtained from the 
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participants before collecting the data. Confidentiality of the participants was 
maintained throughout the study. 
 
Data Collection Procedure 
 
 Data collection is the precise, systematic gathering of information relevant 
to the research purpose. (Polit and Beck) The researcher presented the proposal to 
the ethical committee Apollo hospitals and got ethical clearance to precede the 
study. The investigator collected the data from Apollo children’s hospitals after 
obtaining proper administrative permission from concerned authorities. The 
observation time schedule was from7.30 am to 12 noon and 12.30p.m to 3pm and 
the data collection period was from May 15
th
 to June15th 2013. 
 
 A group of 60 children with intravenous line were selected by purposive  
sampling method and consent was obtained from the parents.  30 children on 
dynaplaster and 30 children tegaderm were selected. The baseline data was 
collected like demographic variable and clinical variable was collected by 
interview. 
 
 Pain perception assessment was done during removal of dynaplaster 
tegaderm by using Wong–Bakers pain Scale, the effectiveness of tegaderm and 
dynaplaster was checked by using observation check list, to assess presence of 
infection during  removal  by using infection check list.  The observation was 
done for 3 consecutive days for each child.  Then the level of satisfaction on 
removal of tegaderm and dynaplaster was assessed among staff nurses. 
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Problems Faced During Data Collection 
 
The problems faced during the data collection were, 
 Lack of time for nurses to participate in the study. 
 Unwillingness of some parents to participate 
 Some parents were asking too many questions 
 
Plan for Data Analysis 
 
Data analysis is the systematic organization, synthesis of research data and 
testing of null hypothesis by using the obtained data (Polit and beck, 2004). 
Analysis and interpretation were carried out using descriptive and inferential 
statistics. Like mean standard deviation, Independent ‘t’ test and chi-square. 
 
Summary 
 
This chapter dealt with selection of research approach, research design, 
setting, population, sample, sampling technique, sampling criteria, selection and 
development of study instruments, validity, reliability of the study pilot study, 
data collection procedure, problems faced during data collection and plan for data 
analysis. 
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CHAPTER IV 
ANALYSIS AND INTERPRETATION 
 
Data analysis is conducted to reduce, organize and give meaning to the 
data. The results obtained from data analysis require interpretation to be 
meaningful. Interpretation of data involves examining the results from data 
analysis forming conclusions, considering the implications for nursing, exploring 
the significance of the findings and suggesting further studies (Burns and Groove, 
2007). 
 
This chapter deals with analysis and interpretation of data collected on a 
number of issues from various sources. Statistics is a field of study concerned with 
techniques or methods of data collection, classification, summarizing, and 
interpretation, drawing inferences, testing of hypothesis and making 
recommendations (Mahajan, 2004). Data was collected from 60 children 
underwent securing IV line plaster at Apollo Children’s Hospital, Chennai, among 
them 30 were in tegaderm and 30 in dynaplaster to determine the effectiveness of 
tegaderm/dynaplaster while removing both plaster. The data were analyzed 
according to the objectives and hypothesis of the study. Analysis of the data was 
compiled after all the data was transferred to master coding sheet. The data were 
analyzed, tabulated and interpreted using appropriate descriptive and inferential 
statistics. 
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Organization of the Findings 
 
 The findings of the study were organized and presented under the 
following headings: 
 Frequency and percentage distribution of demographic variables of children 
using tegaderm versus dynaplaster. 
 Frequency and percentage distribution of clinical variables of children using    
tegaderm versus dynaplaster. 
 Frequency and percentage distribution of pain perception and occurrence 
infection among children using tegaderm versus dynaplaster. 
 Frequency and percentage distribution of effectiveness of tegaderm versus 
dynaplaster among children. 
 Frequency and percentage distribution of level of satisfaction of nurses using 
tegaderm versus dynaplaster.  
 Comparison of mean and standard deviation of pain perception and occurrence 
of infection during removal of tegaderm versus dynaplaster children. 
 Comparison of mean and standard deviation of effectiveness of tegaderm 
versus dynaplaster among  children. 
 Association between selected demographic variables and pain perception of 
children using tegaderm versus dynaplaster using wong bakers faces pain 
rating scale. 
 Association between selected clinical variables and pain perception of children 
using  tegaderm versus dynaplaster.  
 Association between selected demographic variables and occurrence of 
infection of children using tegaderm versus using infection check list 
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 Association between selected clinical variables and occurrence of infection of 
children using tegaderm versus dynaplaster. 
 Association between selected demographic variables and effectiveness of 
tegaderm versus dynaplaster among children.  
 Association between selected clinical variables and effectiveness of tegaderm 
versus dynaplaster among children.  
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Table. 1 
Frequency and Percentage Distribution of Demographic Variables of 
Children using Tegaderm versus Dynaplaster 
(N=60) 
Demographic 
variables 
Tegaderm (n=30) Dynaplaster (n=30) 
 N P N P 
Age of the child     
1 -3  years 15 50% 8 26% 
4-6  years 4 13% 1 17% 
7-9  years 6 20% 2 10% 
10-12 years 5 17% 3 47% 
Gender of the child     
Male 15 50% 18 60 % 
Female 15 50% 12 40% 
Type of family     
Nuclear 16 53% 10 33% 
Joint 14 47% 20 67% 
Area of residence     
Urban 
Rural  
17 
10 
57% 
33% 
17 
10 
57% 
33% 
Suburban 3 10% 3 10% 
  
 
  The above table reveals that most of the children are aged 1-3yrs (50%, 
26%). Significant percentage of children are males (50%, 60%), from nuclear 
family (53%,33%) among children using tegaderm versus dynaplaster.  
Fig.3 depicts that most of their family monthly income is 21000-39000 
(40%,30%) in both tegaderm versus dynaplaster children.    
Fig.4 shows that majority of the children were in primary school (47%, 67%)  
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Fig : 3 Frequency and Percentage Distribution of  family monthly income of children in Tegaderm versus Dynaplaster 
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Fig: 4 Frequency and Percentage Distribution educational level of children in Tegaderm versus Dynaplaster
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Table. 2 
Frequency and Percentage Distribution of Clinical Variables of Children using 
Tegaderm Versus Dynaplaster 
(N=60) 
Clinical Variables Tegaderm  (n=30) Dynaplaster  (n=30) 
 N P N P 
Age of the child when 
diagnosed…..years 
    
1 – 3 14 47% 8 27% 
4 – 6 
7 – 9 
10 -12 
Co-morbid  illness 
4 
6 
5 
13% 
23% 
17% 
6 
3 
13 
20% 
10% 
43% 
Present 1 3 2 7% 
Absent 29 97% 28 93% 
If present specify...... - - - - 
Types of IV line     
Peripheral line 
Central vein 
24 
6 
80% 
20% 
28 
2 
93% 
7% 
Types of adhesive material 
used 
    
Tegaderm 
Dynaplaster 
30 
- 
100% 
- 
- 
30 
- 
100% 
Micro pore 
Durapore 
Number of days 
tegaderm/dynaplaster in situ 
1 -3 days 
3 -5 days 
5-7 days 
- 
- 
 
 
14 
10 
6 
- 
- 
 
 
47% 
33.3% 
20% 
- 
- 
 
 
19 
8 
3 
- 
- 
 
 
83.3% 
16.7% 
10% 
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 The above table reveals that majority of the children with tegaderm and 
dynaplaster had no co morbid illness(97%,93%),significant percentage of children 
had peripheral line (80%,93%). Most of the children were intravenous line 
dependent for more than three days (47%,63%) and secured with tegaderm and 
dynaplaster (47%,83,3%).  
 
Fig. 5 depicts that most of the children fall into the children fall into the category 
of any other diseases like surgical illness 
Fig .6 shows that majority of the children received medications 
Fig. 7 infers that most of the children were in bracheocephalic vein 
Fig .8 shows that most of them were in intravenous line for 1-3 days 
Fig. 9shows that majority of the children had complication in dynaplaster 
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Fig.5 Frequency and Percentage Distribution of Diagnosis of Children
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Fig.6 Frequency and Percentage Distribution of indication for Intravenous line of Children 
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Fig:7 Frequency and Percentage Distribution of site of IV line Insertion of Children
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Fig. 8 Frequency and Percentage Distribution of Intra Venous Line in Situ of Children   
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Fig .9 Frequency and Percentage Distribution of Occurrence of Complications in Children   
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Table. 3 
Frequency and Percentage Distribution of Pain perception and Occurrence 
of Infection among Children using Tegaderm Versus Dynaplaster 
 
 
           This table infers that majority of children with tegaderm had no 
infection during presence (63.3%,80%) and majority of children with 
dynaplaster had infection during presence (75%,43%). 
Fig10: depicts that most of the children had no pain in tegaderm and severe 
pain in dynaplaster. 
Level of infection Tegaderm (n=30) Dynaplaster  (n =30) 
 N P N P 
No infection 24 80% 17 57% 
Infection  6 20% 13 43% 
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Fig:10 Frequency and Percentage Distribution of Pain Perception in Children 
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Table .4 
Frequency and Percentage Distribution of Effectiveness of Tegaderm Versus 
Dynaplaster among Children. 
 
 
 
 The above table infers that majority of the children using tegaderm had 
effective out come with tegaderm   (90%) and (27%) had effective out come with 
dynaplaster. 
 
 
 
 
 
 
 
 
Effectiveness of 
Tegaderm versus 
Dynaplaster 
Tegaderm(n=30) Dynaplaster (n =30) 
 N 
 
P N P 
Effective 27 90% 8 27% 
Moderately effective  3 10% 10 33% 
In effective - - 12 40% 
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Table .5 
Frequency and Percentage Distribution of Level of Satisfaction of Nurses 
using Tegaderm Versus Dynaplaster  
 
 
 
The findings reveals that most of the nurses using tegaderm were highly 
satisfied  (90%), whereas (73%) of nurses using dynaplaster were moderately 
satisfied. 
 
 
 
 
 
 
 
 
 
Level of satisfaction Tegaderm(n=30) Dynaplaster (n =30) 
 N P N P 
Highly satisfied 27 90% - - 
Moderately satisfied 3 10% 22 73% 
Satisfied - - 8 27% 
Dissatisfied - - - - 
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Table. 6 
Comparison of Mean and Standard Deviation of pain perception and 
occurrence of infection during removal of tegaderm versus dynaplaster children 
 
 Pain Perception Occurrence of Infection 
Tegaderm Dynaplaster Tegaderm Dynaplaster 
N 30 30 30 30 
M 1 8.4 0.2 1 
SD 0.9 2.46 0.1 0.4 
t value 23.7*** 4.6*** 
 
***P<0.001 
      This table shows that mean and  standard  deviation with regard to pain 
perception of  children  while removing tegaderm was (M-1.06,SD-0.9) and while 
removing dynaplaster  was (M-8.4,SD-2.46).The difference is significant at 
p<0.05 level. The findings also revealed that the occurrence of infection in 
children while removing tegaderm was (M-0.2, SD-0.1) and while removing 
dynaplaster was (M-1, SD-0.4).The difference is significant at p<0.001 level. 
Hence null hypothesis H01 is rejected. 
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Table. 7 
Comparison of Mean and Standard Deviation of Effectiveness of Tegaderm 
versus Dynaplaster among  Children  
Group N M SD t value 
 
Tegaderm 
 
30 
 
26 
 
2.7 
 
 
17.8*** 
Dynaplaster 30 
 
17 
 
1.2 
 
 
 
***P<0.001 
           The mean and standard deviation with regard to effectiveness of tegaderm 
was (M-26, SD-6.1) and dynaplaster was (M-17,SD-2.6).The difference is 
significant at p<0.001 level. Hence null hypothesis H02 is rejected. 
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Table .8 
Association between Selected Demographic Variables and Pain Perception of Children using 
Tegaderm and Dynaplaster Using Wong Bakers Faces Pain rating Scale 
 
Demographic variables Tegaderm 
Pain perception score 
χ2 Dynaplaster 
Pain perception score 
χ2 
 Up to mean Above mean  Up to mean Above mean  
    N P  
Age of the child       
1 - 6 years 11 8 0.07 13 2 5.25* 
7- 12 years 
Gender of the child 
Male 
Female 
Type of the family 
Nuclear 
Joint 
Area of residence 
7 
 
8 
11 
 
10 
9 
4 
 
7 
4 
 
7 
4 
df=1 
 
1.2 
df=1 
 
2.8 
df=1 
 
7 
 
13 
6 
 
4 
14 
8 
 
5 
6 
 
6 
6 
df=1 
 
1.5 
df=1 
 
3.9 
df=1 
 
Urban/Rural 
Sub urban 
Family income per 
month in rupees 
20001-30000 
30001-40000 
Educational status of 
the children 
Not started formal 
education/kindergarten 
Primary school 
9 
10 
 
 
18 
1 
 
 
6 
 
14 
8 
3 
 
 
4 
7 
 
 
6 
 
4 
1.4 
df=1 
 
 
12.1*** 
df=1 
 
 
2.1 
 
df=1 
8 
11 
 
 
14 
7 
 
 
8 
 
11 
7 
4 
 
 
5 
4 
 
 
2 
 
9 
1.0 
df=1 
 
 
0.31 
df=1 
 
1.75 
df=1 
 
***p<0.001,*p<0.05 
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     The table 8 shows a significant association between  selected demographic 
variables and pain perception with regard to monthly income( 
χ2  =
12.1,df = 1) among 
children with tegaderm and in children with dynaplaster it is age of  the child 
(
χ2
=5.25,df =1) and type of family(
χ2
=3.9,df =1) at p<0.001 p<0.05.Hence  null 
hypothesis H03 is rejected. 
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Table .9 
Association between Selected Clinical Variables and Pain Perception of Children using  Tegaderm 
versus Dynaplaster  
Clinical  variables Tegaderm 
Pain perception score 
χ2 Dynaplaster 
Pain perception  score 
χ2 
 Up to mean Above mean  Up to 
mean 
Above mean  
 N P  N P  
Age of the child when       
1-6 yrs 12 7 2 13 2 5.25* 
7-12 yrs 7 4 df=1 7 8 df=1 
Co morbid illness       
Present 1 0 0.05 2 0 0 
Absent 23 6 df=1 28 0 df=1 
Diagnosis       
Cardiac problem/ infections 
respiratory problem/ any other 
Indications 
Medications/parental nutrition 
Blood transfusion/intravenous 
fluid 
Types of iv line 
Peripheral line 
Central line 
Site of IV line insertion 
Cephalicvein/Bracheo cephalic 
vein 
Jugular/femoral vein 
No of days 
tedagerm/dynaplaster insitu 
1-5 days 
5-7 days 
No of days IV line insitu 
1-5 days 
5-7 days 
Is there any intravenous 
complication noted 
Yes 
No 
9 
10 
 
13 
7 
 
 
13 
6 
 
13 
6 
 
 
 
14 
6 
 
14 
6 
 
 
20 
0 
1 
10 
 
5 
5 
 
 
11 
0 
 
11 
0 
 
 
 
10 
0 
 
10 
0 
 
 
10 
0 
4.3* 
df=1 
 
0.6 
df=1 
 
 
2.12 
df=1 
 
2.13 
df=1 
 
 
 
3.75 
df=1 
 
3.75 
df=1 
 
 
o 
df=1 
2 
17 
 
6 
13 
 
 
18 
0 
 
21 
0 
 
 
 
19 
0 
 
19 
0 
 
 
12 
8 
3 
8 
 
2 
9 
 
 
10 
2 
 
7 
2 
 
 
 
8 
3 
 
8 
3 
 
 
6 
4 
1.49 
df=1 
 
0.47 
df=1 
 
 
2.00 
df=1 
 
 
4.5 
df=1 
 
 
4.78* 
df=1 
 
4.78* 
df=1 
 
 
0 
df=1 
*p<0.05 
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 Table 9, shows that there is a significant association between selected clinical variables 
and pain perception of children using tegaderm  with regard to diagnosis (
χ2  =
4.3,df = 1) 
and in children with dynaplaster it was with regard to   insitu (
χ2
=4.78,df =1), site of 
intravenous line insertion, (
χ2
=4.5,df =1) at p<0.05. Hence null hypothesis H04 is rejected. 
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Table .10 
Association between Selected Demographic Variables and Occurrence of infection of Children 
using Tegaderm versus Dynapalster Using Infection check list 
Demographic variables Tegaderm  
Occurrence of infection 
χ2 Dynaplaster  
Occurrence of infection 
χ2 
 Up to 
mean 
Above mean  Up to mean Above mean  
    N P  
Age of the child       
1 - 6 years 19 0 0 10 4 2.35 
7- 12 years 
Gender of the child 
Male 
Female 
Type of the family 
Nuclear 
Joint 
Area of residence 
11 
 
13 
11 
 
14 
10 
 
0 
 
2 
4 
 
3 
3 
 
df=1 
 
0.36 
df=1 
 
0.12 
df=1 
 
10 
 
14 
6 
 
4 
16 
 
6 
 
4 
6 
 
6 
4 
df=1 
 
2.4 
df=1 
 
4.7* 
df=1 
 
Urban/Rural 
Sub urban 
Family income per month 
in rupees 
20001-30000 
30001-40000 
Educational status of the 
children 
Not started formal 
education/kindergarten 
Primary school 
23 
1 
 
 
21 
8 
 
 
 
13 
10 
4 
2 
 
 
1 
0 
 
 
 
4 
3 
4.39* 
df=1 
 
 
0.11 
df=1 
 
 
 
0.01 
df=1 
 
17 
3 
 
 
13 
7 
 
 
 
7 
13 
8 
2 
 
 
8 
2 
 
 
 
4 
6 
0.19 
df=1 
 
 
0.70 
df=1 
 
 
 
1.52 
*p<0.05 
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We can infer from the above table that there is a significant association  
between  selected demographic variables and  infection among children in 
tegaderm with regard to area of residence, ( 
χ2  =
4.39,df = 1) and in children with 
dynaplaster with regard to type of family(
χ2
=4.7,df =1) at p<0.05. Hence  null 
hypothesis H05 is rejected. 
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Table .11 
Association between Selected Clinical Variables and Occurrence of Infection of Children using 
Tegaderm versus Dynaplaster 
Clinical  variables Tegaderm  
Occurrence  of infection 
χ2 Dynaplaster  
occurrence of infection 
χ2 
 Up to mean Above mean  Up to 
mean 
Above mean  
 N P  N P  
Age of the child when       
1-6 yrs 19 0 0 10 4 2.35 
7-12 yrs 11 0 df=1 10 6 df=1 
Co morbid illness       
Present 1 0 0.05 2 0 0 
Absent 23 6 df=1 28 0 df=1 
Diagnosis       
Cardiac problem/ infections 
respiratory problem/ any other 
Indications 
Medications/parental nutrition 
Blood transfusion/intravenous 
fluid 
Types of iv line 
Peripheral line 
Central line 
Site of IV line insertion 
Cephalic vein / Bracheo 
cephalic vein 
Jugular/femoral vein 
No of days tegaderm 
/dynaplaster insitu 
1-5 days 
5-7 days 
No of days IV line insitu 
1-5 days 
5-7 days 
Is there any intravenous 
complication noted 
Yes 
No 
11 
12 
 
10 
15 
 
 
18 
6 
 
18 
 
4 
 
 
23 
1 
 
23 
1 
 
 
0 
24 
0 
7 
 
4 
1 
 
 
3 
3 
 
6 
 
2 
 
 
4 
2 
 
4 
2 
 
 
0 
6 
2.7 
df=1 
 
2.3 
df=1 
 
 
2.2 
df=1 
 
0.17 
df=1 
 
 
 
4.39* 
df=1 
 
4.39* 
df=1 
 
 
0 
2 
18 
 
5 
15 
 
 
19 
1 
 
19 
 
1 
 
 
23 
1 
 
23 
1 
 
 
7 
6 
3 
7 
 
3 
7 
 
 
9 
1 
 
9 
 
1 
 
 
4 
2 
 
4 
2 
 
 
12 
5 
2.0 
df=1 
 
0.09 
df=1 
 
 
0.39 
df=1 
 
0.39 
df=1 
 
 
 
4.39* 
df=1 
 
4.39* 
df=1 
 
0.9 
df=1 
 
* p<0.05 
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 The above table shows that there is a significant association between 
selected clinical variables and occurrence of infection among children with 
tegaderm and dynaplaster with regard to number of days of intravenous line insitu, 
(χ2 =4.39, df = 1) at p<0.05. Hence null hypothesis H06 is rejected. 
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Table .12 
Association between Selected Demographic Variables and Effectiveness of Tegaderm Versus 
Dynaplaster among Children  
Demographic variables Tegaderm 
Effectiveness score 
χ2 Dynaplaster 
Effectiveness score 
χ2 
 Up to mean Above mean  Up to mean Above mean  
 N P  N P  
Age of the child       
1 - 6 years 9 9 5.0* 9 4 0.57 
7- 12 years 
Gender of the child 
Male 
Female 
Type of the family 
Nuclear 
Joint 
Area of residence 
5 
 
18 
7 
 
9 
6 
 
7 
 
7 
8 
 
7 
8 
 
df=1 
 
0.12 
df=1 
 
0.53 
df=1 
 
11 
 
11 
7 
 
4 
6 
 
6 
 
7 
5 
 
6 
4 
 
df=1 
 
0.22 
df=1 
 
4.78* 
df=1 
 
Urban/Rural 
Sub urban 
Family income per 
month in rupees 
20001-30000 
30001-40000 
Educational status of the 
children 
Not started formal 
education/kindergarten 
Primary school 
13 
1 
 
 
10 
5 
 
 
8 
 
5 
14 
2 
 
 
13 
2 
 
 
8 
 
8 
0.22 
df=1 
 
 
1.3 
df=1 
 
 
0.22 
df=1 
 
 
17 
2 
 
 
14 
6 
 
 
6 
 
12 
10 
1 
 
 
7 
3 
 
 
4 
 
8 
0.09 
df=1 
 
 
0 
df=1 
 
 
0 
df=1 
 
*p<0.05 
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 We can infer that there is a significant association between selected 
demographic variables and effectiveness of tegaderm with regard to age, ( 
χ2  =
5.0,df = 
1) and dynaplaster with regard to  type of family (
χ2
=4.78,df =1) at p<0.05.Hence null 
Hypothesis H07 is rejected. 
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Table .13 
Association between Selected Clinical Variables and Effectiveness of  Tegaderm Versus Dynaplaster 
among Children  
Clinical  variables Tegaderm  group  
Effectiveness score 
χ2 Dynaplaster  
Effectiveness score 
χ2 
 Up to mean Above 
mean 
 Up to 
mean 
Above mean  
 N P  N P  
Age of the child when       
1-6 yrs 
7-12 yrs 
9 
5 
9 
7 
0.24 
df=1 
9 
11 
4 
6 
0.05 
df=1 
Co morbid illness       
Present 0 1 1.62 0 2 2.0 
Absent 16 13 df=1 18 10 df=1 
Diagnosis       
Cardiac problem/ infections 
respiratory problem/ any other 
Indications 
Medications/parental nutrition 
Blood transfusion/intravenous 
fluid 
Types of iv line 
Peripheral line 
Central line 
Site of IV line insertion 
Cephalic vein / Bracheo 
cephalic vein 
Jugular/femoral vein 
No of days 
Tedagerm/Dynaplaster 
insitu 
1-5 days 
5-7 days 
No of days IV line insitu 
1-5 days 
5-7 days 
Is there any intravenous 
complication noted 
Yes 
No 
8 
7 
 
6 
9 
 
 
10 
5 
 
10 
 
5 
 
 
 
12 
2 
 
12 
2 
 
 
0 
15 
3 
12 
 
9 
6 
 
 
14 
1 
 
14 
 
1 
 
 
 
13 
3 
 
13 
3 
 
 
0 
15 
4.2* 
df=1 
 
1.2 
df=1 
 
3.2 
df=1 
 
3.2 
df=1 
 
 
 
 
0.11 
df=1 
 
0.11 
df=1 
 
0 
df=1 
3 
15 
 
2 
16 
 
 
17 
1 
 
17 
1 
 
 
 
 
17 
1 
 
17 
1 
 
 
11 
5 
2 
10 
 
6 
6 
 
 
11 
1 
 
11 
1 
 
 
 
 
10 
2 
 
10 
2 
 
 
8 
6 
0 
df=1 
 
5.37* 
df=1 
 
0.08 
df=1 
 
0.08 
df=1 
 
 
 
 
0.88 
df=1 
 
0.88 
df=1 
 
0.40 
df=1 
*p<0.05                                    
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 We can infer that there is a significant association between selected 
clinical variables and effectiveness of tegaderm with regard to diagnosis, (
χ2  
=
4.2,df = 1)  and dynaplaster with regard to indications for intravenous line (
χ2  
=
5.37,df = 1) at p<0.05.Hence the null hypothesis H08 is rejected. 
 
 
Summary 
This chapter dealt with analysis and interpretation of the data obtained by 
researcher. The analysis showed that pain perception and occurrence of infection 
is reduced in tegaderm and increased in dynaplaster. The level of satisfaction is 
high in nurses using to removal of tegaderm and moderately satisfied with 
dynaplaster. 
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CHAPTER V 
DISCUSSION 
 
Statement of the problem 
 
A Comparative Study to Assess the Effectiveness Of Tegaderm Versus 
Dynaplaster Upon Pain Perception and Occurrence Of Infection During Removal 
Among Children at Selected Hospitals, Chennai. 
 
Objectives of the Study 
 
1. To assess the level of pain perception and occurrence of infection during 
removal of tegaderm versus dynaplaster among children.  
2. To compare the effectiveness of tegaderm versus dynaplaster upon pain 
perception and occurrence of infection among children. 
3. To determine the effectiveness of tegaderm versus dynaplaster among 
children 
4. To determine the association between selected demographic variables 
versus pain perception during removal of tegaderm versus dynaplaster 
among children. 
5. To determine the association between selected clinical variables and pain 
perception during removal of tegaderm versus dynaplaster among children. 
6. To determine the association between selected demographic variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children.  
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7. To determine the association between selected clinical variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children. 
8. To determine the association between selected demographic variables and 
effectiveness of tegaderm versus dynaplaster among children.  
9. To determine the association between selected clinical variables and 
effectiveness of tegaderm versus dynaplaster among children.  
10. To assess the level of satisfaction of nurses using tegaderm versus 
dynaplaster 
  
The conceptual framework of the study was based on king’s Goal 
Attainment Theory. A comparative study with Post-test only design was used. The 
study was conducted at Apollo Children Hospitals, Chennai. The study included 
60 children who were selected by purposive sampling 30 were in the intervention 
group I and 30 were in the intervention group II. The variables of the study were 
pain perception and prevalence of infection.  
 
An extensive review of literature and guidance by experts laid the 
foundation of development of demographic variable proforma, clinical variable 
proforma, effectiveness checklist, infection check list, wong baker’s pain scale 
and rating scale on level of satisfaction of nurses. The data collection tools were 
validated and reliability was established. The main study was conducted after the 
pilot study. 
 
The level of pain perception and prevalence of infection and effectiveness 
was assessed for tegaderm and dynaplaster of children. The level of satisfaction of 
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nurses was assessed among both the groups. The data obtained was analysed using 
descriptive and inferential statistics. 
 
Demographic variables distribution 
 Most of the children were aged 1-3yrs (50%, 26%).Significant percentage 
of  children were males (50%,60%),from nuclear family (53%,33%) with a family 
monthly income of 20000-30000 (40%,30%) and majority of the children were in  
primary school (47%,67%) in both tegaderm and dynaplaster group of children  
respectively. 
 
Owens (2004) in an article proved that on comprehensive review pain 
measured for children aged between 0 and 3 years discussed their applicability to 
the group of children. Search of electronic data based and other electronic sources 
were supplemented by hand review of relevant journals to identify published 
measures for use in children aged between 0 and 3 years. Twenty eight pain 
measures were identified in the literature nine for neonates, ten for infants and 
nine for aged between one and 3 years. 
 
Clinical   variables of children 
 Majority of the children with tegaderm and dynaplaster had no co morbid 
illness(97%,93%), significant percentage of children  had orthopaedic and surgical 
problems (63.3%,83.3%),most of the children received medications(57%,27%) 
through peripheral line (80%,93%) placed in  Bracheo cephalic vein (80%,93%). 
Most of the children were intravenous line dependent for more than three days 
(47%, 63%) and secured with tegaderm and dynaplaster (47%, 83,3%).Sixty 
percent of  children with dynaplaster had complications. 
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 A descriptive study conducted by Vak (2007) on children to view the 
sources of pain and explore the views on pain relief strategies. An exploratory 
cross sectional descriptive design was used to investigate on what aids the 
children to think at the time of experiencing pain. The sample composed of 33% 
boys and 64% girls of 4- 16 years. The result has shown that mean +_S.D:9.25, 
+_3.04 and  few were different from the mean presented in the children texts and 
drawing based on developmental stage and on difference based on gender. 
 
The first objective of the study was to assess the level of pain perception and 
occurrence of infection during removal of tegaderm versus dynaplaster 
among children.  
              
 It was noted that majority of children with tegaderm experienced no pain 
and had no infection during removal (63.3%,80%)and majority of children with 
dynaplaster experienced severe pain and had infection during removal 
(75%,43%). 
 
The above findings of the study is supported by Priyadharshini Johnson 
(2004) to investigate the prevalence of pain and characteristics of pain (frequency, 
duration, intensity) among children. It was then compared across different ages 
and genders. In this study about 735 children from school were surveyed, the 
results showed that 715(97.3%) have answered the questionnaires related to pain 
completely. The study concluded that the prevalence of pain, is increased with age 
and more pain was complained by female children. 
 
The above findings is also supported by Cunha (2008), who performed a 
study on Centrally-placed IV-line infections are a frequent cause of fever in the 
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critical care unit. IV-line infection is not usually accompanied by local signs of 
infection, and usually presents as unexplained fever. The diagnosis should be 
considered only after other cause of fever has been ruled out. The likelihood of 
fever being due to IV.-line infection increases with duration of IV catheterization. 
Skin organisms i.e., Staphylococcus epidermidis/coagulase-negative 
staphylococci, and to a lesser extent, Staphylococcus aureus are the usual 
pathogens in IV line infection. Treatment of IV -line infection involves removal of 
the IV line. Empiric antibiotic therapy directed against gram-positive 
cocci/aerobic gram-negative bacilli is usually started after blood cultures have 
been obtained and removed catheter tip sent for semi quantitative culture. 
 
The second objective of the study was to compare the effectiveness of 
tegaderm versus dynaplaster upon pain perception and occurrence of 
infection among children.  
               
 Mean and  standard  deviation with regard to pain perception of  children  
while removing tegaderm was (M-1.06,SD-0.9) and while removing dynaplaster 
(M-8.4,SD-2.46).The difference was significant at p<0.05 level. The findings also 
revealed that the occurrence of infection in children while removing  tegaderm  
(M-0.2, SD-0.1) and while removing dynaplaster  (M-1, SD-0.4).The difference 
was significant at p<0.001 level. Hence null hypothesis H01 was rejected. 
                 
   Priyadharshini Johnson (2004) in her study on 735 children from school 
she found that 715(97.3%) have answered the questionnaires related to pain 
completely. The study concluded that the prevalence of pain, is increased with age 
and more pain was complained by female children. 
 The researcher found that equal amount pain was there to equal gender. 
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The third objective of the study was to determine the effectiveness of 
tegaderm versus dynaplaster among children 
          
 The mean and standard deviation with regard to effectiveness of tegaderm 
was (M-26, SD-6.1) and dynaplaster group of children was (M-17,SD-2.6).The 
difference was significant at p<0.001 level. The null hypothesis H02 was rejected . 
 
A randomised controlled trial conducted by Tripepi-Bova KA(1998) in 
United States  to compare with gauze dressings, and transparent polyurethane 
dressings (TPDs )reduce patient dislodgment of peripheral intravenous (IV) 
catheters, phlebitis, and insertion site infiltration. 108 patients were allocated to 
TPDs and 121 were allocated to gauze dressings. Fewer patients who had TPDs 
dislodged the IV catheter compared with patients who had gauze dressings (p< 
0.05). Rates of phlebitis and infiltration did not differ, although there was a trend 
toward a lower frequency of phlebitis and infiltration in patients assigned to 
TPDs. They found that transparent polyurethane dressings on peripheral IV sites 
resulted in fewer catheter dislodgments by patients than did gauze dressings. Non-
significant trends for lower rates of phlebitis and IV site infiltration were found 
for patients who had transparent polyurethane dressings. 
 
The fourth objective was to determine the association between selected 
demographic variables and pain perception during removal of tegaderm and 
dynaplaster among children.  
  
 There was significant association between  selected demographic variables 
and pain perception with regard to monthly income( 
χ2  =
12.1,df = 1) among 
children with tegaderm and in children with dynaplaster age of child (
χ2
=5.25,df 
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=1) , type of family(
χ2
=3.9,df =1) at p<0.001, p<0.05 level. Hence null hypothesis 
H03 was rejected. 
  
The fifth objective of the study was to determine the association between 
selected clinical variables and pain perception during removal of tegaderm 
and dynaplaster among children. 
            
  There was significant association between selected clinical variables and 
pain perception in children on tegaderm  with regard to diagnosis ( 
χ2  =
4.3,df = 
1)and in children with dynaplaster with regard to  dynaplaster insitu (
χ2
=4.78,df 
=1), site of intravenous line insertion, (
χ2
=4.5,df =1) at p<0.05. The null 
hypothesis H04 was rejected. 
 
The researcher found that according to the diagnosis the pain will be 
increased because most of the children have surgical conditions in this study. 
       
The sixth objective of the study was to determine the association between 
selected demographic variables and occurrence of infection during presence 
of tegaderm versus dynaplaster among children.  
          
 There was significant association between the selected demographic 
variables and presence of infection among children with tegaderm in regard to 
area of residence, (χ2 =4.39, df = 1) and in children with dynaplaster with regard to 
type of family (
χ2
=4.7,df =1) at p<0.05 dynaplaster. The null hypothesis H05 was 
rejected. 
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The seventh objective of the study was to determine the association between 
selected clinical variables and occurrence of infection during presence of 
tegaderm versus dynaplaster among children. 
           
   There was significant association between the selected clinical variables 
and presence of infection among children with tegaderm and dynaplaster with 
regard to number of days of intravenous line insitu, (χ2 =4.39, df = 1) at p<0.05. 
The null hypothesis H06 was rejected. 
  
 Thus the researcher concluded that the number of days of IV line insitu 
increases the chance of infection. 
 
The eight objective of the study was to determine the association between 
selected demographic variables and effectiveness of tegaderm versus 
dynaplaster among children.  
    
 There was significant association between the selected demographic 
variables and effectiveness of tegaderm  with regard to age, ( 
χ2  =
5.0,df = 1) and 
dynaplaster with regard to  type of family(
χ2
=4.78,df =1) at p<0.05. The null 
Hypothesis H07 was rejected. 
 
The researcher felt that more effective with tegaderm than dynaplaster 
because tegaderm was easy to apply and remove, water resistant, there is no 
allergies in site of application and there is no skin breakdown at the time of 
removal. 
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The nineth objective of the study was to determine the association between 
selected clinical variables and effectiveness of tegaderm versus dynaplaster 
among children.  
           
 There was significant association between selected clinical variables and 
effectiveness of tegaderm  with regard to diagnosis, ( 
χ2  =
4.2,df = 1)  and 
dynaplaster with regard to indications for intravenous line (
χ2  =
5.37,df = 1) at 
p<0.05. The null hypothesis H08 was rejected. 
 
The tenth objective of the study was to assess the level of satisfaction of 
nurses using tegaderm and dynaplaster 
          
  The findings revealed that most of the tegaderm group of nurses were 
highly satisfied with tegaderm (90%), whereas (73%) of nurses using dynaplaster 
were moderately satisfied (73%). 
  
 Hence the researcher concluded that nurses using IV line felt more 
satisfied with tegaderm when compared with dynaplaster. 
 
Similar results were obtained by Palefski and Stoddard (2001) a study was 
performed  on assessed complications in 776 peripheral catheters-639 inserted by 
infusion nurses and 137 by generalist nurses. Thirty-six percent (36%) of catheters 
inserted by the generalists and 20% inserted by infusion nurses were removed for 
complications (P<= .001). Cellulites, infection, and sepsis were tracked by clinical 
signs and symptoms, but none were reported in either group. 
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Summary 
 This study has dealt with the discussion of findings in the present study 
which includes pain perception, prevalence of infection, effectiveness of tegaderm 
and dynaplaster and nurses satisfaction   of intervention group I and intervention 
group II of children. 
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CHAPTER VI 
SUMMARY, CONCLUSION, IMPLICATION AND RECOMMENDATON 
  
 The heart of the research project is in reporting the findings. This chapter 
gives a brief account of the present study including the conclusion drawn from the 
findings, nursing implications of the study and recommendations. 
 
Summary 
 
A Comparative Study to Assess the Effectiveness of Tegaderm Versus 
Dynaplaster Upon Pain Perception and Occurrence Of Infection During Removal 
Among Children at Selected Hospitals, Chennai. 
 
Objectives of the study 
 
1. To assess the level of pain perception and occurrence of infection during 
removal of tegaderm versus dynaplaster among children.  
2. To compare the effectiveness of tegaderm versus dynaplaster upon pain 
perception and occurrence of infection among children. 
3. To determine the effectiveness of tegaderm versus dynaplaster among 
children 
4. To determine the association between selected demographic variables and 
pain perception during removal of tegaderm versus dynaplaster among 
children. 
5. To determine the association between selected clinical variables and pain 
perception during removal of tegaderm versus dynaplaster among children. 
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6. To determine the association between selected demographic variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children.  
7. To determine the association between selected clinical variables and 
occurrence of infection during presence of tegaderm versus dynaplaster 
among children. 
8. To determine the association between selected demographic variables and 
effectiveness of tegaderm versus dynaplaster among children.  
9. To determine the association between selected clinical variables and 
effectiveness of tegaderm versus dynaplaster among children.  
10. To assess the level of satisfaction of nurses using tegaderm and 
dynaplaster 
 
Null Hypothesis 
 
Ho1 There will be no significant difference between the pain perception and 
occurrence infection  among children during removal of tegaderm versus 
dynaplaster 
Ho2 There will be no significant difference in the effectiveness of tegaderm versus 
dynaplaster. 
Ho3 There will be no significant association between selected demographic 
variables and pain perception of children during removal of tegaderm versus 
dynaplaster. 
Ho4 There will be no significant association between selected clinical variables 
and pain perception of children during removal of tegaderm versus dynaplaster. 
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Ho5 There will be no significant association between selected demographic 
variables and occurrence of infection among children during presence of tegaderm 
versus dynaplaster. 
Ho6 There will be no significant association between selected clinical variables 
and occurrence of infection among children during presence tegaderm versus 
dynaplaster. 
Ho7 There will be no significant association between selected demographic 
variables and effectiveness tegaderm versus dynaplaster. 
Ho8 There will be no significant association between selected clinical variables 
and effectiveness of tegaderm versus dynaplaster. 
              
 The conceptual framework for the study was developed on the basis of 
kings Goal attainment theory, which was modified for the present study. An 
intensive review of literature and experts guidance laid the foundation to the 
development of tools such as demographic variable proforma and clinical variable 
proforma for children, infection check list, effectiveness checklist, pain 
assessment scale, and nurse’s satisfaction checklist. 
              
  An evaluative –post test only design for children, was adopted for 
conducting the study. The present study was conducted at Apollo children’s 
hospital tegaderm versus dynaplaster of children respectively. The sample size for 
the present study was 60 in that 30 Tegaderm and 30 in Dynaplaster  who satisfied 
the inclusion criteria. 
               
 Investigator used the demographic variable and clinical variable proforma 
for children to obtain the baseline data. Check list was used to check the infection 
to identify weather children was receiving the infections, pain scale to assess the 
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pain perception while removing the tegaderm/dynaplaster. Check list was used to 
check the effectiveness of weather best in the tegaderm or dynaplaster. Rating 
scale to assess the level of nurse’s satisfaction regarding both plasters. The data 
collection tools were validated and reliability was established. After the main 
study , the data collection for the main study was conducted for 6 weeks. The 
collected data was tabulated and analysed by using appropriate descriptive and 
inferential statistics.  
 
The Major Findings of the Study 
 
Demographic variables of children 
               Most of the children were aged 1-3yrs (50%,26%) .Significant 
percentage of  children were males (50%,60%) ,from nuclear family (53%,33%) 
with a family monthly income of 20000-30000 (40%,30%) and majority of the 
children were in  primary school (47%,67%) in both tegaderm & dynaplaster 
group of children  respectively. 
  
Clinical variables of children 
             Majority of the children with tegaderm and dynaplaster had no co morbid 
illness(97%,93%), significant percentage of children  had orthopaedic and surgical 
problems (63.3%,83.3%),most of the children received medications(57%,27%) 
through peripheral line (80%,93%) placed in  Bracheo cephalic vein (80%,93%). 
Most of the children were intravenous line dependent for more than three days 
(47%,63%) and secured with tegaderm and dynaplaster (47%,83,3%).Sixty 
percent of  children with dynaplaster had complications. 
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Frequency and Percentage Distribution of Pain perception and Occurrence 
of Infection among Children using Tegaderm Versus Dynaplaster 
 
It was noted that majority of children with tegaderm experienced no pain 
and had no infection during removal (63.3%,80%)and majority of children with 
dynaplaster experienced severe pain and had infection during removal 
(75%,43%). 
 
Frequency and Percentage Distribution of Effectiveness of Tegaderm Versus 
Dynaplaster among Children. 
 
 It was noted that majority of the children using tegaderm had effective out 
come (90%) and (27%) had effective out come with dynaplaster. 
 
 Frequency and Percentage Distribution of Level of Satisfaction of Nurses 
using Tegaderm Versus Dynaplaster  
  
 The findings revealed that most of the tegaderm group of nurses were 
highly satisfied with tegaderm (90%), whereas (73%) of nurses using dynaplaster 
were moderately satisfied (73%). 
 
Comparison of Mean and Standard Deviation of pain perception and 
occurrence of infection during removal of tegaderm versus dynaplaster 
children 
 
Mean and  standard  deviation with regard to pain perception of  children  
while removing tegaderm was (M-1.06,SD-0.9) and while removing dynaplaster 
(M-8.4,SD-2.46).The difference was significant at p<0.001 level.  
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 The findings also revealed that the occurrence of infection in children 
while removing  tegaderm  (M-0.2, SD-0.1) and while removing dynaplaster  (M-
1, SD-0.4).The difference was significant at p<0.001 level. Hence null hypothesis 
H01 was rejected. 
 
Comparison of Mean and Standard Deviation of Effectiveness of Tegaderm 
versus Dynaplaster among Children  
  
 The mean and standard deviation with regard to effectiveness of tegaderm 
was (M-26,SD-6.1) and dynaplaster group of children was (M-17,SD-2.6).The 
difference was significant at p<0.001 level. The null hypothesis H02 was rejected. 
 
Association between Selected Demographic Variables and Pain Perception of 
Children using Tegaderm and Dynaplaster Using Wong Bakers Faces Pain 
rating Scale 
          
 There was significant association between  selected demographic variables 
and pain perception with regard to monthly income( 
χ2  =
12.1,df = 1) among 
children with tegaderm and in children with dynaplaster age of child (
χ2
=5.25,df 
=1) , type of family(
χ2
=3.9,df =1) at p<0.001,p<0.05.Hence  null hypothesis H03 
was rejected. 
 
Association between Selected Clinical Variables and Pain Perception of 
Children using Tegaderm versus Dynaplaster 
  
 There was significant association between selected clinical variables and 
pain perception in children on tegaderm  with regard to diagnosis ( 
χ2  =
4.3,df = 1) 
and in children with dynaplaster with regard to dynaplaster insitu  (
χ2
=4.78, df =1), 
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site of intravenous line insertion, (
χ2
=4.5,df =1) at p<0.05. The null hypothesis H04 
was rejected.  
 
Association between Selected Demographic Variables and Occurrence of 
infection of Children using Tegaderm versus Dynapalster Using Infection 
check list 
 
 There was significant association between the selected demographic 
variables and presence of infection among children with tegaderm in regard to 
area of residence, ( 
χ2  =
4.39,df = 1) and in children with dynaplaster with regard to 
type of family(
χ2
=4.7,df =1) at p<0.05 dynaplaster. The null hypothesis H05 was 
rejected.  
 
Association between Selected Clinical Variables and Occurrence of Infection 
of Children using Tegaderm versus Dynaplaster 
 
There was significant association between the selected clinical variables 
and presence of infection among children with tegaderm and dynaplaster with 
regard to number of days of intravenous line insitu, (χ2 =4.39, df = 1) at p<0.05. 
The null hypothesis H06 was rejected. 
 
Association between selected demographic variables and effectiveness of 
tegaderm versus dynaplaster among children 
  
  There was significant association between the selected demographic 
variables and effectiveness of tegaderm  with regard to age, ( 
χ2  =
5.0,df = 1) and 
dynaplaster with regard to  type of family(
χ2
=4.78,df =1) at p<0.05. The null 
Hypothesis H07 was rejected. 
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Association between selected clinical variables and effectiveness of tegaderm 
versus dynaplaster among children 
 There was significant association between selected clinical variables and 
effectiveness of tegaderm  with regard to diagnosis, (
χ2=
4.2,df = 1) and dynaplaster 
with regard to indications for intravenous line (
χ2  =
5.37, df = 1) at p<0.05. The 
null hypothesis H08 was rejected. 
 
Conclusion 
 
 The findings of the study revealed that the pain perception, prevalence of 
infection, and effectiveness is better in tegaderm while applications, and removing 
in intravenous line securement whereas major variation is noted in the 
dynaplaster. Thus study concludes that tegaderm is the best securing intravenous 
line and decreased pain while removing the plasters. 
 
Implications 
 
 The findings of the study has implications in the different branches of 
nursing profession i.e. Nursing practice, Nursing administration, Nursing 
education, Nursing theory, Nursing research. 
 
Nursing practice 
           The findings of the study revealed that the intravenous line is the important 
for the injections and bolus doses for medications in intensive care units, wards, 
operation theatre are in need of securing is the initiation to maintain the patency. 
In that securing is very important using appropriate plasters for securement mean 
while free from infections, complications and also so many days present in the 
skin so much sticky over the skin. So, cant able to remove while removing so 
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much of pain perceive the children so that can reducing the pain, infection and 
complications using a correct securement of plaster. The best effective strategies 
of securing and splinting, fixing the tegaderm should be avoiding too much of 
tight and too much of loose more important is while removing pain will not 
perceive the children. 
 
With the above mentioned strategies tegaderm is found to be effective. All 
nurses play a vital role in caring intravenous line children. Tegaderm removal of 
technique can be known for the nurses to follow a better removing tegaderm and 
to create awareness among nurses and helps to have evidence practice. 
 
Nursing education 
 With the emerging health care demands and newer trends in the field of 
nursing education, we must focus on the innovations to enhance the nursing care. 
The nursing students should be taught the removal of technique of the tegaderm. 
Therefore student nurses should be taught the clinical importance of intravenous 
line securing and removal decreased pain perception. Demonstration of proper 
technique and use of simulation in the clinical setup helps the students to acquire 
an adequate knowledge and incorporate it in their practice. 
 
Nursing administration 
 With technological advances and ever growing challenges of health care, 
administrators have the responsibility to provide continuing nursing education 
opportunities to understand the intervention in improving securing the intravenous 
line and removal. 
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 The enables the nurses to update the knowledge and to render the cost 
effective care to the children. The nurse administrators can train the nurses to 
identify the best method. Nurse administrators must periodically organize formal 
training programme to nurse for the removal of the tegaderm plaster intravenous 
line securing children. Awareness can be created among the nurses regarding the 
benefits of tegaderm in order to promote its use in clinical set up. 
 
Nursing research 
 The professionals and the students can conduct further studies on cavelon 
precautions in both tegaderm versus dynaplaster. There is a need for extensive 
research in this area. Nurse researcher should appraise challenges and should 
perform scientific work by taking part in assessment, applications, evaluations, 
removal, for intravenous line securing plaster. The researcher can bring the 
researched techniques in to practice. 
 
Researcher must focus on various measures in maintaining patient line, 
securing, prevent the complications of intravenous line in children. Tegaderm can 
be implemented to intravenous line securing and easy to removal and apply to 
attain a better out come. 
 
Nursing theory 
 The conceptual and theories models exclusively for pain perception for 
children on intravenous line removal are yet to be developed by nursing theorist. 
In this study is based on Modified king’s goal attainment theory which can be 
used to educate and guide the nurses. 
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Recommendations 
 
 A study can be conducted on cost effectiveness of tegaderm versus 
dynaplaster. 
 A similar study can be done on umbilical vein securing in preterm babies. 
 A similar study can be done on a larger population to generalize results. 
 A study can be conducted to assess the occurrence of infection tegaderm pads 
used for surgical dressing among post operative children. 
 Similar study can be done on Endo tracheal tube intubation securing in 
preterm, term, neonates and children. 
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APPENDIX V 
LETTER REQUESTING OPINIOS AND SUGGESTIONS OF THE EXPERTS 
FOR ESTABILISHING CONTENT VALIDITY OF RESEARCH TOOL 
From  
Ms.Premalatha., 
M.Sc., (Nursing) II Year,  
Apollo College of Nursing,  
Chennai-95.  
 
To  
Forwarded Through:  
Dr. Latha Venkatesan,  
Principal,  
Apollo College of Nursing.  
 
Sub: Request for opinions and suggestions of experts for content validity of 
Research tool.  
 
Respected Sir/ Madam  
Greetings! As a part of the Curriculum Requirement the following research title is 
selected for the study.  
“A comparative study to assess the effectiveness of tegaderm versus 
dynaplaster upon pain perception and occurrence of infection during 
removal among children at Selected Hospitals, Chennai”. I will be highly 
privileged to have your valuable suggestions with regard to the establishment of 
Content Validity of Research tool. So, I request you to validate my Research tool 
and give suggestions about the tool.  
                                                                                                      Yours Sincerely,  
                                                                                                   (MS. T. Premalatha) 
     
 
 
xxi 
 
APPENDIX VI 
LIST OF EXPERTS FOR CONTENT VALIDITY 
 
1. Dr. Latha Venkatesan, M.Sc (N). M.Phil., Ph.D.,  
Principal,  
Apollo College of Nursing,   
Chennai-95.  
2.Mrs.Kalpana bharani kumar, MBBS, MRCPH., 
Consultant  Paediatric & Neonatalgist 
Apollo Speciality Hospitals, 
Chennai-95.  
3. Mrs.Vijayalakshmi,  M.Sc. (N), Ph.D., M.A .Psychology., 
Professor,  
Department of Mental Health Nursing,  
Apollo College of Nursing,  
Chennai.  
4. Mrs. Nesa Sathya Satchi, M.Sc. (N).,Ph.D., 
Professor,  
Department of Child Health Nursing,  
Apollo College  of  Nursing, 
 Chennai.  
5.Mrs. J.Jaslina Gnanarani, M.Sc(N) 
Reader  
Department of Medical Surgical Nursing,   
Apollo College of Nursing,  
Chennai. 
6. Mrs.Jamuna Rani, M.Sc (N) 
Reader,  
Department of Child Health Nursing,  
Apollo College of Nursing,  
Chennai-95.  
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APPENDIX VII 
CERTIFICATE FOR CONTENT VALIDITY 
 
           I hereby certify that I have validated the Research tool and interventional 
programme of Ms.T,PREMALATHA M.Sc. (Nursing) 2
nd
yr student who is 
undertaking research study.  
 
A comparative study to assess the effectiveness of tegaderm versus 
dynaplaster upon pain perception and prevalence of infection during removal 
among children at selected hospitals, Chennai. 
 
 
Signature of expert 
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APPENDIX VIII 
LETTER SEEKING PERMISSION TO USE THE TOOL 
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APPENDIX IX 
RESEARCH PARTICIPANT CONSENT FORM 
 
Dear participant, 
 
              I am M.Sc. Nursing 2
nd
 year student of Apollo College of 
Nursing,Chennai. As a part of my study, I have selected a Reserch Project on  
“A Comparative Study to assess the Effectiveness of Tegaderm Versus 
Dynaplaster upon Pain Perception and occurrence of Infection during Removal 
among Children at Selected Hospitals, Chennai”. 
  
 I hereby seek your consent and co-operation to participate in the study. 
Please  Be frank and honest in your response. The information collected will be 
kept confidential and anonymity will be maintained. 
 
                                                                                      Signature of the Researcher 
 
 
         I ….......................................................... ,  here by consent to participate and 
undergo the study. 
 
 
                                                                                       Signature of the Participant 
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CERTIFICATE FOR ENGLISH EDITING 
TO WHOMSOEVER IT MAY CONCERN 
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APPENDIX XI 
DEMOGRAPHIC VARIABLE 
 
Purpose: 
This proforma is used by the researcher to collect information on the 
demographic variables of children such as age, developmental stage, gender, birth 
weight, present weight, religion, type of family, area of residence and family 
monthly income. 
 
Instructions: 
The researcher will collect the information by interviewing the mother and by 
reviewing case sheet for relevant details.  
 
Sample number.........   
UHID NUMBER................   
 
1. Age of the child in................... yrs  
1.1   1 - 3 
1.2   4 - 6 
1.3   7 - 9 
1.4  10-12 
2. Gender 
2.1 Male 
2.2 Female  
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3. Type of family  
3.1   Nuclear 
3.2   Joint  
4. Area of residence 
4.1 Urban  
4.2 Rural 
4.3 Sub urban 
5. Family monthly income in Rupees 
5.1   < 20,000  
5.2   30,000  
5.3   > 40,000  
6. Educational status of the children  
6.1   Not Started Formal Education 
6.2   Kinder Garten  
6.3   Primary School 
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APPENDIX XII 
CLINICAL VARIABLE 
Purpose:   
This proforma is used by the researcher to collect information on the 
clinical variables of children such as age of diagnosis, type of intra venous line, 
present illness, types of adhesive material, present illness, number of days of line 
insitu etc. 
 
Instructions: 
          The researcher will collect the information by interviewing the nurses and 
by reviewing the hospital records of the children. 
1. Age of the child when diagnosed--------------- years 
 1.1   1 – 3  
 1.2   4 – 6  
 1.3   7 – 9 
 1.4    10- 12  
2. co-morbid illness 
 2.1    Present  
 2.2    Absent  
2.3    If present specify................ 
3. Diagnosis...............  
 3.1 Cardiac Disease 
 3.2 Infections  
 3.3 Respiratory Disease 
 3.4 Any Other (Specify)...................... 
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4. Indication for Intravenous line 
 4.1 Medications 
 4.2 Parental Nutrition 
 4.3 Blood Transfusion 
 4.4 Intravenous Fluids 
5. Type of intravenous line 
 5.1 Peripheral Line 
 5.2 Central Line 
6. Site of intravenous line insertion 
 6.1 Cephalic Vein 
 6.2 Bracheo Cephalic Vein  
 6.3 Jugular vein 
 6.4 femoral vein 
7. Type of adhesive material used  
 7.1 Tegaderm 
 7.2 Dynaplaster 
 7.3 Micro pore 
 7.4 Durapore 
8. Number of days of tegaderm / dynaplaster in situ 
 8.1   1 – 3 Days 
 8.2   3 - 5 Days 
 8.3   5- 7 Days 
 
 
 
xxx 
 
9. Number of days of Intravenous line in situ 
 9.1    1- 3 days 
 9.2     3 -5 days 
 9.3     5-7 days 
10. Is there any intravenous complication noted? 
 10.1   Yes 
 10.2   No 
 10.3    If yes specify................................. 
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APPENDIX XIII 
PAIN ASSESSMENT SCALE (WONG BAKERS SCALE) 
Purpose: 
    This is a standardized scale used to measure the pain perception of children 
during removal of plaster as scored by researcher. 
 
Instructions: 
   The researcher observes and documents the pain perception of the children 
undergoing removal of plaster by pointing out the each face using the words to 
identify the pain perception. 
 
                              0  No hurt 
                              2 Hurts little bit 
                              4 Hurts little more 
                              6 Hurts even more 
                              8 Hurts whole lot 
                              10 Hurts worst 
 
Score interpretation 
0             : No pain 
2             : Mild pains 
4 &6       : Moderate pain 
8 &10     : Severe pain  
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APPENDIX XIV 
BLUE PRINT OF CHECK LIST ON OCCURENCE OF INFECTION OF 
VERSUS TEGADERM DYNAPLASTER 
 
S.NO INFECTION CHECK 
LIST 
ITEM NO TOTAL NO 
OF ITEM 
PERCENTAGE 
1. Fever 1,2,3,4, 4 50% 
2. 
 
Infection 5,6,7,8,  
 
4 50% 
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APPENDIX XV 
OBSERVATIONAL CHECK LIST ON INFECTION OCCURENCES 
DURING USE OF TEGADERM VERSUS DYNAPLASTER 
Purpose 
This check list was prepared by the researcher to assess the occurrence 
infection during use of tegaderm/dynaplaster. 
Instructions 
The researcher will collect the information by observing site after removal 
of tegaderm/dynaplaster to determine the infections. 
 
S.NO SIGNS IF INFECTION 
 
YES NO 
1  Fever (>101 degree) ferenhit   
2 Urticaria   
3 Pain at the site of cannula insertion   
4 Redness   
5 Tenderness    
6 Area around the site of cannula insertion is 
warm to touch 
  
7 Discharge at the site of cannula insertion   
8 Edema  at the site of cannula insertion   
 
Score                       percentage                            Interpretation 
<4                             <50                                           No infection         
5 – 8                        50 – 100                                     Infection 
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APPENDIX XVI 
BLUE PRINT OF RATING SCALE ON EFFECTIVENESS OF 
TEGADERM VERSUS DYNAPLASTER 
 
SNO ITEM 
GROUPING 
ITEM 
NO 
TOTAL 
NUMBER OF 
ITEM 
PERCENTAGE 
1 Advantages of 
adhesive material  
4,6 2 20% 
2 Disadvantages 2,3,7,10 4 40% 
3 Complications 5,8,9 3 20% 
4 Cost  1 1 10% 
 Total  10 100% 
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APPENDIX XVII 
OBSERVATIONAL CHECK LIST ON EFFECTIVENESS OF 
TEGADERM VERSUS DYNAPLASTER 
Purpose 
This check list is designed to analyse the effectiveness of 
tegaderm/dynaplaster. 
Instructions: 
The researcher uses this check list to find out the effectiveness of the 
tegaderm, Versus dynaplaster. 
 
S.NO Features/Components EFFECTIVE MODERATELY 
EFFECTIVE 
INEFFECTIVE 
1 Easy to apply    
2 Needed frequent change.     
3 Affordable    
4 Water resistant    
5  occurrence of infections    
6 Easy to remove.    
7 
 
Needed additional 
splinting. 
   
8 
 
Allergies in site of 
application. 
   
9 
 
Skin break down at the time 
of removal. 
   
10 Adherence after removal    
 
Score                   Percentage           Interpretation 
< 10                         <33                       Ineffective 
11 – 20                    34 – 66                       Moderately effective 
21 – 30                 67 – 100                      Effective 
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APPENDIX XVIII 
BLUE PRINT OF RATING SCALE ON LEVEL OF SATISFACTION OF 
TEGADERM VERSUS DYNAPLASTER  
 
S.NO ITEM GROUPING ITEM NO TOTAL NO 
OF ITEM 
PERCENTAGE 
1. Approach of the 
researcher 
1,2,3,4,5 5 50% 
2. 
 
Characteristics of the 
interventions 
6,7,8,9,10 
 
5 
 
50% 
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APPENDIX XIX 
 
RATING SCALE TO ASSESS THE LEVEL OF SATISFACTION OF 
NURSES REGARDING TEGADERM VERSUS DYNAPLASTER UPON 
DURING REMOVAL OF PLASTER AMONG CHILDREN. 
 
Purpose:  
  The rating scale is used by the nurses to assess the level of satisfaction of 
nurses during removal of tegaderm and dynaplaster. 
 
Instructions: 
  The rating scale consists of 10 items kindly give your responses freely and 
frankly. The data collected will be confidential. The responses range from highly 
satisfied to dissatisfied with score of 4, 3, 2, 1, respectively 
S.No Questions Highly 
Satisfied (4) 
Moderately 
Satisfied(3) 
Satisfied 
(2) 
Dissatisfied 
(1) 
1 
 
 
Prior information given 
about the removal of 
tegaderm/dynaplaster. 
    
2 
 
The courtesy of the 
researcher. 
    
3 
 
Presence of investigator 
during removal. 
    
4 
 
Approach of the 
researcher. 
    
5 
 
Knowledge of the 
researcher regarding the 
intervention. 
    
xxxviii 
 
6 
 
 
Anxiety level of the 
children while removing 
tegaderm/dynaplaster. 
    
7 
 
 
Children’s pain perception 
while removing 
tegaderm/dynaplaster. 
    
8 
 
 
Time taken to calm the 
children after removal of 
tegaderm / dynaplaster. 
    
9 
 
Durability of 
tegaderm/dynaplaster. 
    
10 
 
 
 
Time consumption to 
remove 
tegaderm/dynaplaster 
    
 
 
Score Interpretations: 
Score          Percentage          Interpretation 
<10                       <25                            Dissatisfied 
11-20                    26 -50                      Satisfied 
21-30                    51 -75                      Moderately satisfied 
31-40                 76 -100                   Highly satisfied 
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APPENDIX XX 
DATA CODE SHEET 
DEMOGRAPHIC VARIABLES PERFORMA 
 
1. AGE: Age of the child in................... yrs  
1.1   1 - 3 
1.2   4 - 6 
1.3   7 - 9 
1.4  10-12 
2.GEN: Gender 
2.1 Male 
2.2 Female  
3. FAM: Type of family  
       3.1   Nuclear 
       3.2   Joint  
     4. RES: Area of residence 
       4.1 Urban  
       4.2 Rural 
       4.3 Sub urban 
     5.INC: Family monthly income in Rupees 
       5.1   > 20,000  
       5.2   30,000  
       5.3   < 40,000  
    6.EDU: Educational status of the children  
       6.1   Not Started Formal Education 
       6.2   Kinder Garten  
       6.3   Primary School 
xl 
 
APPENDIX  XXI 
DATA CODE SHEET 
CLINICAL VARIABLE 
 
1. AGE: Age of the child when diagnosed--------------- years 
 1.1   1 – 3  
 1.2   4 – 6  
 1.3   7 – 9 
 1.4    10- 12  
 
2. CMI: co-morbid illness 
 2.1    Present  
 2.2    Absent  
2.3    If present specify................ 
 
3. DIA: Diagnosis...............  
 3.1 Cardiac Disease 
 3.2 Infections  
 3.3 Respiratory Disease 
 3.4 Any Other (Specify)...................... 
 
4. IND: Indication for Intravenous line 
 4.1 Medications 
 4.2 Parental Nutrition 
 4.3 Blood Transfusion 
 4.4 Intravenous Fluids 
 
xli 
 
5. TIVL: Type of intravenous line 
 5.1 Peripheral Line 
 5.2 Central Line 
6. SIVLI: Site of intravenous line insertion 
 6.1 Cephalic Vein 
 6.2 Bracheo Cephalic Vein  
 6.3 Scalp Vein 
 6.4 Dorsalis Pedis 
7. TAMU: Type of adhesive material used  
 7.1 Tegaderm 
 7.2 Dynaplaster 
 7.3 Micro pore 
 7.4 Durapore 
8. NOD: Number of days of tegaderm / dynaplaster in situ 
 8.1   1 – 3 Days 
 8.2   3 - 5 Days 
 8.3   5- 7 Days 
9. NODILS: Number of days of Intravenous line in situ 
 9.1    1- 3 days 
 9.2     3 -5 days 
 9.3     5-7 days 
10. CI: Is there any intravenous complication noted? 
 10.1   Yes 
 10.2   No 
 10.3 If yes specify................................. 
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Demographic Variable Clinical Variable  
Pain 
Infection 
Score 
Effectiveness  Score LSN 
S.No AGE GEN FAM RES INC EDU AGE CMI DIA IND TIVL SIVLI TAMU NOD NODILS CI            
1 1.1 2.1 3.1 4.2 5.3 6.1 I.1 2.2 3.4 4.1 5.1 6.2 7.1 8.2 9.2 10.2 2 0 27 37 
2 1.2 2.1 3.2 4.1 5.2 6.3 1.2 2.2 3.4 4.4 5.1 6.2 7.1 8.2 9.2 10.2 0 0 27 36 
3 1.3 2.1 3.1 4.1 5.1 6.3 1.3 2.2 3.1 4.4 5.1 6.2 7.1 8.3 9.3 10.2 0 0 29 40 
4 1.3 2.2 3.1 4.1 5.1 6.3 1.3 2.2 3.1 4.4 5.1 6.2 7.1 8.3 9.3 10.2 0 0 27 30 
5 1.2 2.1 3.1 4.2 5.1 6.2 1.2 2.2 3.1 4.1 5.1 6.2 7.1 8.3 9.3 10.2 0 0 19 36 
6 1.1 2.2 3.2 4.1 5.1 6.2 1.2 2.2 3.4 4.4 5.1 6.2 7.1 8.1 9.1 10.2 0 0 26 40 
7 1.2 2.2 3.2 4.2 5.1 6.3 1.2 2.2 3.1 4.4 5.1 6.2 7.1 8.3 9.3 10.2 0 0 20 37 
8 1.1 2.2 3.1 4.1 5.3 6.1 1.1 2.2 3.4 4.4 5.1 6.2 7.1 8.1 9.1 10.2 2 0 24 40 
9 1.1 2.1 3.1 4.1 5.3 6.1 1.1 2.2 3.4 4.4 5.1 6.2 7.1 8.2 9.2 10.2 4 0 24 40 
10 1.1 2.1 3.1 4.1 5.3 6.1 1.1 2.2 3.4 4.4 5.1 6.2 7.1 8.1 9.1 10.2 4 0 30 30 
11 1.3 2.2 3.2 4.1 5.1 6.3 1.3 2.2 3.4 4.1 5.1 6.2 7.1 8.2 9.2 10.2 4 1 27 40 
12 1.3 2.2 3.1 4.3 5.2 6.3 1.3 2.2 3.4 4.1 5.1 6.2 7.1 8.1 9.1 10.2 0 1 30 40 
13 1.1 2.2 3.2 4.3 5.2 6.2 1.1 2.2 3.4 4.1 5.1 6.2 7.1 8.1 9.1 10.2 4 1 27 35 
14 1.1 2.2 3.2 4.2 5.2 6.1 1.1 2.2 3.4 4.1 5.1 6.2 7.1 8.2 9.2 10.2 0 0 28 35 
15 1.1 2.1 3.1 4.2 5.2 6.1 1.1 2.2 3.4 4.1 5.1 6.2 7.1 8.2 9.2 10.2 0 1 28 36 
16 1.3 2.2 3.2 4.2 5.2 6.3 1.4 2.2 3.4 4.1 5.1 6.2 7.1 8.2 9.2 10.2 0 1 29 40 
17 1.1 2.1 3.2 4.1 5.2 6.1 1.3 2.2 3.4 4.1 5.1 6.2 7.1 8.3 9.3 10.2 0 0 27 36 
18 1.2 2.1 3.2 4.1 5.2 6.3 1.4 2.2 3.4 4.1 5.1 6.2 7.1 8.1 9.2 10.2 0 0 28 36 
19 1.1 2.2 3.1 4.1 5.3 6.2 1.1 2.2 3.1 4.1 5.2 6.3 7.1 8.3 9.3 10.2 0 0 26 40 
20 1.4 2.2 3.2 4.1 5.2 6.3 1.3 2.2 3.1 4.1 5.2 6.3 7.1 8.1 9.1 10.2 0 0 20 37 
21 1.1 2.2 3.2 4.2 5.1 6.1 1.1 2.2 3.1 4.1 5.2 6.3 7.1 8.1 9.1 10.2 0 0 24 40 
22 1.4 2.2 3.2 4.2 5.2 6.3 1.3 2.2 3.1 4.4 5.2 6.3 7.1 8.1 9.1 10.2 0 0 25 40 
23 1.3 2.1 3.1 4.1 5.2 6.3 1.3 2.2 3.4 4.4 5.1 6.2 7.1 8.1 9.1 10.2 0 0 26 40 
24 1.4 2.1 3.1 4.1 5.3 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.1 8.1 9.1 10.2 4 0 26 40 
25 1.1 2.1 3.2 4.1 5.2 6.2 1.1 2.2 3.4 4.1 5.1 6.2 7.1 8.1 9.1 10.2 2 1 23 30 
26 1.1 2.1 3.1 4.1 5.3 6.1 1.1 2.2 3.4 4.1 5.1 6.2 7.1 8.1 9.1 10.2 2 0 26 40 
27 1.4 2.1 3.1 4.1 5.3 6.3 1.4 2.2 3.2 4.4 5.1 6.2 7.1 8.2 9.2 10.2 2 0 26 40 
28 1.1 2.1 3.1 4.2 5.1 6.2 1.1 2.2 3.1 4.1 5.1 6.4 7.1 8.2 9.2 10.2 0 0 25 30 
29 1.4 2.2 3.2 4.2 5.1 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.1 8.1 9.1 10.2 2 0 28 36 
30 1.1 2.2 3.2 4.3 5.1 6.2 1.1 2.2 3.1 4.1 5.2 6.4 7.1 8.2 9.2 10.2 0 0 28 36 
 
 
APPENDIX XXII 
MASTER CODE SHEET 
TEGADERM  
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Demgraphic Variable  Clinical Variable  Pain 
Score 
Infection Score Effectiveness Score LSN 
S.No AGE GEN FAM RES INC EDU AGE CMI DIA IND TIVL SIVLI TAMU NOD NODILS CI 
1 1.4 2.2 3.2 4.2 5.3 6.3 1.4 2.2 3.1 4.4 5.2 6.2 7.2 8.3 9.3 10.3 10 1 16 21 
2 1.4 2.2 3.1 4.1 5.1 6.3 1.4 2.2 3.4 4.1 5.2 6.2 7.2 8.1 9.1 10.1 6 1 18 26 
3 1.1 2.1 3.2 4.2 5.3 6.2 1.1 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 0 17 23 
4 1.3 2.1 3.1 4.1 5.2 6.3 1.3 2.1 3.4 4.4 5.1 6.2 7.2 8.3 9.3 10.1 10 1 19 26 
5 1.4 2.1 3.2 4.1 5.1 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 6 0 16 23 
6 1.4 2.2 3.2 4.1 5.3 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 0 18 15 
7 1.4 2.2 3.2 4.1 5.2 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 1 17 21 
8 1.1 2.1 3.2 4.1 5.1 6.1 1.1 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 6 0 19 15 
9 1.2 2.1 3.2 4.1 5.3 6.2 1.2 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 0 17 25 
10 1.2 2.1 3.2 4.1 5.3 6.2 1.2 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 0 17 25 
11 1.1 2.1 3.2 4.1 5.2 6.1 1.1 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 1 16 25 
12 1.4 2.1 3.2 4.1 5.2 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 1 16 25 
13 1.4 2.1 3.2 4.2 5.3 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.2 6 0 18 20 
14 1.1 2.1 3.2 4.1 5.1 6.1 1.1 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 6 0 16 20 
15 1.2 2.1 3.2 4.1 5.2 6.3 1.2 2.1 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.2 8 0 18 25 
16 1.4 2.2 3.1 4.1 5.3 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.2 9.1 10.2 10 1 18 21 
17 1.3 2.1 3.1 4.3 5.2 6.3 1.3 2.2 3.4 4.1 5.1 6.2 7.2 8.1 9.2 10.1 8 0 20 26 
18 1.3 2.1 3.2 4.1 5.1 6.3 1.3 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 10 0 17 23 
19 1.1 2.1 3.2 4.2 5.1 6.1 1.1 2.2 3.4 4.1 5.1 6.2 7.2 8.3 9.3 10.2 10 0 19 26 
20 1.2 2.2 3.2 4.2 5.2 6.3 1.2 2.2 3.4 4.4 5.1 6.2 7.2 8.2 9.2 10.2 8 0 15 23 
21 1.1 2.2 3.1 4.1 5.3 6.3 1.1 2.2 3.4 4.4 5.1 6.2 7.2 8.2 9.2 10.1 10 3 17 15 
22 1.4 2.1 3.1 4.3 5.1 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.2 9.2 10.2 8 4 17 21 
23 1.2 2.1 3.1 4.2 5.1 6.2 1.2 2.2 3.4 4.1 5.1 6.2 7.2 8.2 9.2 10.1 8 3 19 15 
24 1.4 2.2 3.2 4.2 5.2 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.2 10.1 10 2 16 25 
25 1.4 2.2 3.1 4.3 5.1 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.2 9.2 10.1 10 2 17 25 
26 1.1 2.1 3.2 4.2 5.2 6.1 1.2 2.2 3.4 4.4 5.1 6.2 7.2 8.2 9.2 10.1 10 3 16 25 
27 1.4 2.1 3.2 4.1 5.3 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 10 2 16 25 
28 1.1 2.2 3.1 4.1 5.1 6.1 1.3 2.2 3.1 4.1 5.1 6.2 7.2 8.2 9.2 10.2 8 2 18 20 
29 1.4 2.2 3.2 4.2 5.1 6.3 1.4 2.2 3.4 4.4 5.1 6.2 7.2 8.1 9.1 10.1 8 2 16 20 
30 1.4 2.2 3.1 4.2 5.1 6.3 1.1 2.2 3.1 4.1 5.2 6.4 7.2 8.2 9.1 10.2 10 2 18 25 
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APPENDIX XXIII 
PHOTOGRAPHS DURING IV PLASTER (TEGADERM) REMOVAL 
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PHOTOGRAPHS DURING IV PLASTER (DYNAPLASTER) REMOVAL 
 
 
 
 
 
